{"content":"<li class=\"n-box-item date-title\" data-end=\"1557201599\" data-start=\"1557115200\" data-txt=\"Monday, December 23, 2019\">Monday, May  6, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3459579\" data-ts=\"1557196336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459579-catalyst-pharmaminus-42-after-fda-oks-firdapse-competitor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma -42% after FDA OKs Firdapse competitor</a></h4><ul><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"red\">-42.7%</font> after-hours following the Food and Drug Administration's <a href=\"https://www.marketwatch.com/story/catalyst-pharma-stock-plummets-after-fda-approves-competitors-drug-2019-05-06\" target=\"_blank\">approval of a competitor</a> to its Firdapse drug that helps patients who suffer from Lambert-Eaton myasthenic syndrome, for which CPRX charges a list price of $375K.</li><li>The <a href=\"https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder\" target=\"_blank\">FDA approved</a> a version of the drug offered by privately-held Jacobus Pharmaceutical intended for marketing for pediatric use, while Firdapse is recommended only for use in adults; by approving the drug for children, the agency is making it possible for  physicians to prescribe the Jacobus drug for any patient, regardless of  age.</li><li>CPRX shares had hit a 52-week high during today's regular trading session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459579\" data-linked=\"Catalyst Pharma -42% after FDA OKs Firdapse competitor\" data-tweet=\"$CPRX - Catalyst Pharma -42% after FDA OKs Firdapse competitor https://seekingalpha.com/news/3459579-catalyst-pharmaminus-42-after-fda-oks-firdapse-competitor?source=tweet\" data-url=\"https://seekingalpha.com/news/3459579-catalyst-pharmaminus-42-after-fda-oks-firdapse-competitor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459577\" data-ts=\"1557193166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSMT\" target=\"_blank\">OSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459577-osmotica-up-47-after-hours-on-positive-rvl-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osmotica up 47% after hours on positive RVL data</a></h4><ul><li>Thinly traded micro cap Osmotica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a>) is up <font color=\"green\">47%</font> after hours on increased volume in reaction to <a href=\"https://seekingalpha.com/pr/17501134-osmotica-pharmaceuticals-plc-announces-positive-topline-results-phase-iii-clinical-trials\" target=\"_blank\">successful results</a> from a Phase 3 clinical trial, Study 202, evaluating once-daily eye drop RVL (oxymetazoline hydrochloride ophthalmic solution, 0.1%) in patients with blepharoptosis (droopy eyelid).</li><li>Patients receiving RVL experienced a statistically significant improvement in visual field compared to placebo.</li><li>The results were consistent with an earlier Phase 3, Study 201.</li><li>In a long-term safety study, the rates of adverse events in the RVL arm and placebo arm were 31.8% and 29.9%, respectively. Two participants experienced serious adverse events but neither was considered treatment-related.</li><li>The company plans to file a U.S. marketing application next quarter.</li><li>Management will host a conference call tomorrow, May 7, at 12 noon ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459577\" data-linked=\"Osmotica up 47% after hours on positive RVL data\" data-tweet=\"$OSMT - Osmotica up 47% after hours on positive RVL data https://seekingalpha.com/news/3459577-osmotica-up-47-after-hours-on-positive-rvl-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3459577-osmotica-up-47-after-hours-on-positive-rvl-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459576\" data-ts=\"1557192070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENT\" target=\"_blank\">XENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459576-intersect-ent-down-17-after-hours-on-ceo-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intersect ENT down 17% after hours on CEO departure</a></h4><ul><li>Intersect ENT (NASDAQ:<a href='https://seekingalpha.com/symbol/XENT' title='Intersect ENT, Inc.'>XENT</a>) <a href=\"https://seekingalpha.com/pr/17500963-intersect-ent-announces-ceo-transition-plan\" target=\"_blank\">announces </a>that CEO Lisa Earnhardt will resign on June 5 to accept another position while maintaining her board membership.</li><li>Lead director Kieran Gallahue, Executive Chairman effective tomorrow, will assume the CEO role on an interim basis until a successor is hired.</li><li>Shares are down <font color=\"red\">17%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459576\" data-linked=\"Intersect ENT down 17% after hours on CEO departure\" data-tweet=\"$XENT - Intersect ENT down 17% after hours on CEO departure https://seekingalpha.com/news/3459576-intersect-ent-down-17-after-hours-on-ceo-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/3459576-intersect-ent-down-17-after-hours-on-ceo-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459575\" data-ts=\"1557191582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWST\" target=\"_blank\">TWST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459575-twist-bio-readies-stock-offering-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twist Bio readies stock offering; shares down 6% after hours</a></h4><ul><li>Twist Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/TWST' title='Twist Bioscience Corporation'>TWST</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1581280/000119312519138279/d718217ds1.htm\" target=\"_blank\">preliminary prospectus</a> for a 3M-share offering of common stock. Underwriters over-allotment will be an additional 450K shares. Price has yet to be determined.</li><li>Shares are down <font color=\"red\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459575\" data-linked=\"Twist Bio readies stock offering; shares down 6% after hours\" data-tweet=\"$TWST - Twist Bio readies stock offering; shares down 6% after hours https://seekingalpha.com/news/3459575-twist-bio-readies-stock-offering-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3459575-twist-bio-readies-stock-offering-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459572\" data-ts=\"1557183424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRTA\" target=\"_blank\">FRTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459572-forterra-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forterra beats by $0.11, beats on revenue</a></h4><ul><li>Forterra (NASDAQ:<a href='https://seekingalpha.com/symbol/FRTA' title='Forterra, Inc.'>FRTA</a>): Q1 GAAP EPS of -$0.39 <span style=\"color:green\">beats by $0.11</span>.</li><li>Revenue of $291.9M (+0.7% Y/Y) <font color=\"green\">beats by $16.06M</font>.</li><li>Shares <font color=\"green\">+2%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17501292-forterra-announces-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459572\" data-linked=\"Forterra beats by $0.11, beats on revenue\" data-tweet=\"$FRTA - Forterra beats by $0.11, beats on revenue https://seekingalpha.com/news/3459572-forterra-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459572-forterra-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459570\" data-ts=\"1557182896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMC\" target=\"_blank\">FMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459570-fmcplus-4-following-q1-beat-upward-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC +4% following Q1 beat, upward full-year guidance</a></h4><ul><li>FMC Corp. (NYSE:<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a>) is on the move after reporting better than expected <a href=\"https://seekingalpha.com/news/3459493-fmc-beats-0_10-revenue-line\" target=\"_blank\">Q1 earnings</a> and a 7% Y/Y rise in revenues to $1.19B while raising FY 2019 expectations.</li><li>FMC says Q1 Latin America sales  gained 30% Y/Y and greater than 40% excluding forex,  driven mainly by Brazil, with strong growth in sales for cotton, soybean and sugarcane applications, and strong pricing across the region; North America sales rose 7%, driven by demand in pre-emergent herbicides for soybeans and insecticides for tree fruits and vegetables.</li><li>FMC issues above consensus earnings guidance for Q2, seeing EPS of $1.60-$1.70 vs. $1.57 analyst consensus estimate, on revenues of $1.185B-$1.215B vs. $1.21B consensus.</li><li>For the full year, FMC sees EPS of $5.62-$5.82, raised from its previous guidance of $5.55-$5.75 and mostly above $5.64 consensus, on revenues of $4.5B-$4.6B from  $4.45B-$4.55B previously and $4.52B consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459570\" data-linked=\"FMC +4% following Q1 beat, upward full-year guidance\" data-tweet=\"$FMC - FMC +4% following Q1 beat, upward full-year guidance https://seekingalpha.com/news/3459570-fmcplus-4-following-q1-beat-upward-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3459570-fmcplus-4-following-q1-beat-upward-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459567\" data-ts=\"1557181185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459567-solaredge-surges-after-strong-q1-result-upside-q2-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarEdge surges after strong Q1 result, upside Q2 revenue guidance</a></h4><ul><li>SolarEdge Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies, Inc.'>SEDG</a>) <font color=\"green\">+16.5%</font> after-hours as it reports a solid <a href=\"https://seekingalpha.com/news/3459373-solaredge-technologies-beats-0_07-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat and a 29% Y/Y rise in revenues, including record revenues from solar products of $253M, while guiding Q2 revenues above analyst expectations.</li><li>SEDG says Q1 non-GAAP gross margin climbed to 32.8% from 30.9% in Q4 2018 but fell from 38.4% in the year-ago quarter.</li><li>For Q2, SEDG sees revenues of $310M-$320M vs. $281M analyst consensus estimate; the company expects Q2 overall gross margin of 32%-34% and gross margin from sale of solar products of 33%-35%</li></ul><div class=\"tiny-share-widget\" data-id=\"3459567\" data-linked=\"SolarEdge surges after strong Q1 result, upside Q2 revenue guidance\" data-tweet=\"$SEDG - SolarEdge surges after strong Q1 result, upside Q2 revenue guidance https://seekingalpha.com/news/3459567-solaredge-surges-after-strong-q1-result-upside-q2-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3459567-solaredge-surges-after-strong-q1-result-upside-q2-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459557\" data-ts=\"1557178946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459557-mosaic-cuts-full-year-earnings-guidance-sending-shares-skidding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mosaic cuts full-year earnings guidance, sending shares skidding</a></h4><ul><li>Mosaic (NYSE:<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a>) <font color=\"red\">-2.6%</font> after-hours as it issues in-line <a href=\"https://seekingalpha.com/news/3459528-mosaic-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings</a> but lowers full-year earnings guidance, now seeing EPS of $1.50-$2.00 vs. $2.10-$2.50 previously and $2.20 analyst consensus estimate.</li><li>MOS reports Q1 adjusted EBITDA of $430M, compared to $399M in the prior year period, but reduces its full-year EBITDA guidance to $2B-$2.3B from $2.2B-$2.4B previously, reflecting the  impact of curtailments and higher costs associated with the impact of new tailings dam regulations in Brazil, the increase in Canadian resource taxes, and delayed recovery in phosphate margins.</li><li>MOS says higher costs affected all its businesses during Q1, including costs associated with impacts of weather in North America and regulatory changes in Brazil.</li><li>Three Mosaic Fertilizantes mines are currently curtailed as the company executes its plan to meet new regulatory requirements for tailings dams; MOS expects to ship as much as 600K mt of rock from its Peruvian mine, replacing ~40% of the Brazilian mines' normal output.</li><li>Also, depending upon the timing of the mines' return to full operation, MOS plans to ship up to 300K incremental mt of finished phosphates from its Florida production facilities to Brazilian customers.</li><li>MOS expects the higher delivered cost of Miski Mayo rock, combined with the costs of underutilization of mines and chemical plants, to raise expenses by $50M in Q2 and as much as $100M in the full year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459557\" data-linked=\"Mosaic cuts full-year earnings guidance, sending shares skidding\" data-tweet=\"$MOS - Mosaic cuts full-year earnings guidance, sending shares skidding https://seekingalpha.com/news/3459557-mosaic-cuts-full-year-earnings-guidance-sending-shares-skidding?source=tweet\" data-url=\"https://seekingalpha.com/news/3459557-mosaic-cuts-full-year-earnings-guidance-sending-shares-skidding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459553\" data-ts=\"1557178606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459553-aig-sedg-txmd-and-xent-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG, SEDG, TXMD and XENT among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies, Inc.'>SEDG</a> <font color=\"green\">+18.5%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color=\"green\">+10.2%</font>. <a href='https://seekingalpha.com/symbol/APT' title='Alpha Pro Tech, Ltd.'>APT</a> <font color=\"green\">+9.3%</font>. <a href='https://seekingalpha.com/symbol/AIG' title='American International Group, Inc.'>AIG</a> <font color=\"green\">+6.4%</font>. <a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a> <font color=\"green\">+5.7%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/XENT' title='Intersect ENT, Inc.'>XENT</a> <font color=\"red\">-14.0%</font>. <a href='https://seekingalpha.com/symbol/SNDX' title='Syndax Pharmaceuticals, Inc.'>SNDX</a> <font color=\"red\">-11.7%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color=\"red\">-11.0%</font><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD, Inc.'>TXMD</a> <font color=\"red\">-8.8%</font>. <a href='https://seekingalpha.com/symbol/FRAC' title='Keane Group, Inc.'>FRAC</a> <font color=\"red\">-6.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459553\" data-linked=\"AIG, SEDG, TXMD and XENT among after hour movers\" data-tweet=\"$SEDG $AVID $APT - AIG, SEDG, TXMD and XENT among after hour movers https://seekingalpha.com/news/3459553-aig-sedg-txmd-and-xent-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459553-aig-sedg-txmd-and-xent-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459548\" data-ts=\"1557178013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXD\" target=\"_blank\">PXD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459548-pioneer-natural-tops-q1-estimates-closes-sale-to-become-permian-pure-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pioneer Natural tops Q1 estimates, closes sale to become Permian &#39;pure play&#39;</a></h4><ul><li>Pioneer Natural Resources (NYSE:<a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a>) <font color=\"green\">+2.3%</font> after-hours as it easily beats analyst expectations for <a href=\"https://seekingalpha.com/news/3459482-pioneer-natural-resources-beats-0_20-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues as Permian Basin production stays strong.</li><li>PXD says Q1 Permian Basin oil production averaged 203K bbl/day with total Permian output averaging 320K boe/day, both above the top end of company guidance.</li><li>PXD maintains its full-year Permian drilling, completions and facilities capital budget range of $2.8B-$3.1B, which it expects will be fully funded with $3.75B in forecast 2019 cash flow.</li><li>The company maintains its plan to operate an average of 21-23 horizontal rigs in the Permian Basin during 2019, and expects to place 265-290 wells on production, compared to 270 wells placed on production during 2018, with an average estimated ultimate recovery of ~1.6M boe/well.</li><li>At this activity level, PXD expects to deliver 2019 Permian production of 320K-335K boe/day and 203K-213K bbl/day for 12%-17% growth over 2018 levels.</li><li>PXD says it closed the sale of its Eagle Ford shale and remaining south Texas assets to Ensign Natural Resources for $475M, making it a Permian \"pure play.\"</li><li>PXD also expects corporate restructuring efforts will save as much as $100M/year in G&amp;A costs and create a flatter organization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459548\" data-linked=\"Pioneer Natural tops Q1 estimates, closes sale to become Permian &#39;pure play&#39;\" data-tweet=\"$PXD - Pioneer Natural tops Q1 estimates, closes sale to become Permian &#39;pure play&#39; https://seekingalpha.com/news/3459548-pioneer-natural-tops-q1-estimates-closes-sale-to-become-permian-pure-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3459548-pioneer-natural-tops-q1-estimates-closes-sale-to-become-permian-pure-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459531\" data-ts=\"1557177073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVID\" target=\"_blank\">AVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459531-avid-techplus-9-on-q1-beats-financing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Tech +9% on Q1 beats, financing</a></h4><ul><li>Avid Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>) <font color=\"green\">soars 9%</font> after Q1 beats with 6% Y/Y revenue growth.</li><li>The company also reported a financing agreement amendment with $100M in additional bank debt at a reduced interest rate and improved terms, which will provide flexible capital through May 2023. AVID will use the proceeds to purchase 2% convertible notes due June 2020.</li><li>In-line Q2 guidance has revenue from $97M to $105M (consensus: $101.98M). The FY19 outlook has revenue from $420M to $430M (consensus: $424.22M) and adjusted EBITDA of $60M to $65M.</li><li><a href=\"https://seekingalpha.com/pr/17500997-avid-technology-announces-q1-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459474-avid-beats-0_04-beats-revenue\" target=\"_blank\">Avid beats by $0.04, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459531\" data-linked=\"Avid Tech +9% on Q1 beats, financing\" data-tweet=\"$AVID - Avid Tech +9% on Q1 beats, financing https://seekingalpha.com/news/3459531-avid-techplus-9-on-q1-beats-financing?source=tweet\" data-url=\"https://seekingalpha.com/news/3459531-avid-techplus-9-on-q1-beats-financing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459530\" data-ts=\"1557176927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459530-big-day-for-centene-on-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big day for Centene on takeover chatter</a></h4><ul><li>Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) <font color=\"green\">gained 6.6%</font> today after <a href=\"https://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&amp;q=cnc\" target=\"_blank\">StreetInsider reported</a> that Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) has expressed interest in a friendly takeover if CNC backs away from its planned <a href=\"https://seekingalpha.com/news/3445972-centene-acquire-wellcare-17_3b\" target=\"_blank\">acquisition</a> of WellCare Health Plans (NYSE:<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a>). Apparently, certain CNC shareholders plan to challenge the WCG deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459530\" data-linked=\"Big day for Centene on takeover chatter\" data-tweet=\"$CNC $HUM $WCG - Big day for Centene on takeover chatter https://seekingalpha.com/news/3459530-big-day-for-centene-on-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3459530-big-day-for-centene-on-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459520\" data-ts=\"1557176608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459520-biodelivery-sciences-up-2-after-hours-on-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences up 2% after hours on Q1 beat</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) <a href=\"https://seekingalpha.com/pr/17501002-biodelivery-sciences-reports-strong-first-quarter-2019-results-raises-belbuca-full-year\" target=\"_blank\">Q1 results</a> ($M): Revenues: 19.8 (+75.2%); product sales: 19.8 (+102.0%).</li><li>Net loss: (3.8) (+65.1%); loss/share: (0.05) (+72.2%).</li><li>Cash flow ops: (2.9) (+57.4%).</li><li><strong>2019 guidance</strong>: Net sales: $92M - 100M (unch); Belbuca: $83M - 88M from $80M - 85M; cash flow ops positive by year-end.</li><li>Shares are up <font color=\"green\">2%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459374-biodelivery-sciences-beats-0_03-beats-revenue\" target=\"_blank\">BioDelivery Sciences beats by $0.03, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459520\" data-linked=\"BioDelivery Sciences up 2% after hours on Q1 beat\" data-tweet=\"$BDSI - BioDelivery Sciences up 2% after hours on Q1 beat https://seekingalpha.com/news/3459520-biodelivery-sciences-up-2-after-hours-on-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3459520-biodelivery-sciences-up-2-after-hours-on-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459502\" data-ts=\"1557176076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOMA\" target=\"_blank\">XOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459502-xoma-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XOMA beats by $0.08, beats on revenue</a></h4><ul><li>XOMA (NASDAQ:<a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a>): Q1 GAAP EPS of $0.21 <span style=\"color:green\">beats by $0.08</span>.</li><li>Revenue of $8.13M (+1667.4% Y/Y) <font color=\"green\">beats by $3.91M</font>.</li><li>Shares <font color=\"green\">+1.97%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501115-xoma-reports-first-quarter-2019-financial-results-operating-highlights\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459502\" data-linked=\"XOMA beats by $0.08, beats on revenue\" data-tweet=\"$XOMA - XOMA beats by $0.08, beats on revenue https://seekingalpha.com/news/3459502-xoma-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459502-xoma-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459496\" data-ts=\"1557175893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YETI\" target=\"_blank\">YETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459496-yetiminus-3-after-disclosing-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yeti -3% after disclosing share sale</a></h4><ul> <li>Yeti Holdings (NYSE:<a href='https://seekingalpha.com/symbol/YETI' title='YETI Holdings, Inc.'>YETI</a>) trades lower after the company discloses that a holder is offering to sell 9.5M shares.</li> <li><a href=\"https://seekingalpha.com/filing/4474420\" target=\"_blank\">SEC Form S-1</a></li> <li>Shares of Yeti are <font color=\"red\">down 2.75%</font> AH to $29.32</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459496\" data-linked=\"Yeti -3% after disclosing share sale\" data-tweet=\"$YETI - Yeti -3% after disclosing share sale https://seekingalpha.com/news/3459496-yetiminus-3-after-disclosing-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3459496-yetiminus-3-after-disclosing-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459488\" data-ts=\"1557175641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459488-gluminus-5-despite-q1-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu -5% despite Q1 revenue beat</a></h4><ul><li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) <font color=\"red\">drops 5.1%</font> after Q1 results beat revenue estimates with an 18% Y/Y growth and in-line EPS.</li><li>The Q2 outlook has bookings from $100M to $102M, and the FY19 view has $445M to $455M.</li><li>Q1 bookings grew 7% Y/Y to $92.6M.</li><li>Gross margin was 64% compared to the 62.3% in last year's quarter.</li><li>The company says it saw positive early results from the global rollout of Design Home meta features.</li><li>Upcoming titles (May to August launch): WWE Universe, Diner DASH Adventures, and Disney Sorcerer\u2019s Area.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glu.com%2Finvestors&amp;esheet=51980096&amp;newsitemid=20190506005699&amp;lan=en-US&amp;anchor=www.glu.com%2Finvestors&amp;index=1&amp;md5=dae0968ff4c45c81a733a2f0b4ce159c\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17500961-glu-reports-first-quarter-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459365-glu-mobile-beats-revenue\" target=\"_blank\">Glu Mobile beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459488\" data-linked=\"Glu -5% despite Q1 revenue beat\" data-tweet=\"$GLUU - Glu -5% despite Q1 revenue beat https://seekingalpha.com/news/3459488-gluminus-5-despite-q1-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3459488-gluminus-5-despite-q1-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459486\" data-ts=\"1557175561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459486-aigplus-7_6-after-stunning-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG +7.6% after stunning Q1 beat</a></h4><ul><li>American International Group (NYSE:<a href='https://seekingalpha.com/symbol/AIG' title='American International Group, Inc.'>AIG</a>) <font color=\"green\">jumps 7.6% </font>in after-hours trading after Q1 adjusted EPS of $1.58 surges past consensus estimate of $1.06 and improves from $1.04 in the year-ago quarter.</li><li>Q1 General Insurance achieved a combined ratio of 97.4 vs. 103.8 a year earlier, and an accident year combined ratio, as adjusted, of 96.1 vs. 99.7.</li><li>Q1 consolidated net investment income of $3.9B increased from $3.3B in the year-ago quarter, reflecting favorable market performance.</li><li>\"General Insurance achieved an underwriting profit driven by underwriting and expense discipline, improved business mix and reinsurance actions,\" said President and CEO Brian Duperreault. \"We achieved an underwriting profit on a calendar year and accident year basis in the first quarter and we expect that to continue for the full year.\"</li><li>Sees Life and Retirement continuing to deliver low-to-mid-teens adjusted ROCE and double-digit adjusted ROCE for consolidated AIG within three years.</li><li>Q1 adjusted ROCE of 11.6% vs. 7.7% in the year-ago quarter; core adjusted ROCE was 13.4% vs. 8.6%.</li><li>Adjusted book value per common share of $55.47 at March 31, 2019 fell from $56.10 at March 31, 2018.</li><li><a href=\"https://www.aig.com/investor-relations/webcasts-and-presentations\" target=\"_blank\">Conference call </a>on May 7 at 8:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459418-american-international-group-beats-0_52\" target=\"_blank\">American International Group beats by $0.52</a>, May 6, 2019</li></ul><div class=\"tiny-share-widget\" data-id=\"3459486\" data-linked=\"AIG +7.6% after stunning Q1 beat\" data-tweet=\"$AIG - AIG +7.6% after stunning Q1 beat https://seekingalpha.com/news/3459486-aigplus-7_6-after-stunning-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3459486-aigplus-7_6-after-stunning-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459479\" data-ts=\"1557175033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459479-lannett-fq3-earnings-down-17-above-views-shares-up-7-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lannett FQ3 earnings down 17% but above views, shares up 7% after hours</a></h4><ul><li>Lannett Company (NYSE:<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a>) fiscal Q3<a href=\"https://seekingalpha.com/pr/17501071-lannett-announces-fiscal-2019-third-quarter-financial-results-raises-guidance-fiscal-2019\" target=\"_blank\"> results</a> ($M): Net sales: 172.8 (-0.9%); anti-psychosis: 20.6 (+121.5%); cardiovascular: 22.8 (+23.2%).</li><li>Net income: 10.6 (-17.2%); non-GAAP net income: 26.6 (-12.8%); EPS: 0.27 (-15.2%); non-GAAP EPS: 0.68 (-15.0%).</li><li><strong>2019 guidance</strong>: Net sales: $640M - 645M from $615M - 635M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459416-lannett-beats-0_04-beats-revenue\" target=\"_blank\">Lannett beats by $0.04, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459479\" data-linked=\"Lannett FQ3 earnings down 17% but above views, shares up 7% after hours\" data-tweet=\"$LCI - Lannett FQ3 earnings down 17% but above views, shares up 7% after hours https://seekingalpha.com/news/3459479-lannett-fq3-earnings-down-17-above-views-shares-up-7-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3459479-lannett-fq3-earnings-down-17-above-views-shares-up-7-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459474\" data-ts=\"1557174932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVID\" target=\"_blank\">AVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459474-avid-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid beats by $0.04, beats on revenue</a></h4><ul><li>Avid (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>): Q1 Non-GAAP EPS of $0.11 <span style=\"color:green\">beats by $0.04</span>; GAAP EPS of -$0.01.</li><li>Revenue of $103.32M (+5.5% Y/Y) <font color=\"green\">beats by $2.54M</font>.</li><li>Shares <font color=\"green\">+10.75%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17500997-avid-technology-announces-q1-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459474\" data-linked=\"Avid beats by $0.04, beats on revenue\" data-tweet=\"$AVID - Avid beats by $0.04, beats on revenue https://seekingalpha.com/news/3459474-avid-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459474-avid-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459471\" data-ts=\"1557174879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTIC\" target=\"_blank\">OTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459471-otonomy-beats-0_06-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Otonomy beats by $0.06, misses on revenue</a></h4><ul><li>Otonomy (NASDAQ:<a href='https://seekingalpha.com/symbol/OTIC' title='Otonomy, Inc.'>OTIC</a>): Q1 GAAP EPS of -$0.39 <span style=\"color:green\">beats by $0.06</span>.</li><li>Revenue of $0.19M (-36.7% Y/Y) <font color=\"red\">misses by $0.03M</font>.</li><li>Shares <font color=\"green\">+2.05%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501083-otonomy-reports-first-quarter-2019-financial-results-provides-corporate-update\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459471\" data-linked=\"Otonomy beats by $0.06, misses on revenue\" data-tweet=\"$OTIC - Otonomy beats by $0.06, misses on revenue https://seekingalpha.com/news/3459471-otonomy-beats-0_06-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459471-otonomy-beats-0_06-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459468\" data-ts=\"1557174834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459468-rent-centerplus-3-on-improved-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center +3% on improved results</a></h4><ul> <li>Rent-A-Center (NASDAQ:<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center, Inc.'>RCII</a>) trades higher after <a href=\"https://seekingalpha.com/pr/17501052-rent-center-inc-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> EPS came in ahead of even the highest estimate turned in by analysts.</li> <li>Consolidated same-store sales were up 6.8% during the quarter. The company says its cash position increased due to the strong performance, resulting in net debt of 1.4X adjusted EBITDA.</li> <li>Shares of RCII are <font color=\"green\">up 2.99%</font> AH to $25.80.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459453-rent-center-beats-0_24-beats-revenue\" target=\"_blank\">Rent-A-Center beats by $0.24, beats on revenue</a> (May 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459468\" data-linked=\"Rent-A-Center +3% on improved results\" data-tweet=\"$RCII - Rent-A-Center +3% on improved results https://seekingalpha.com/news/3459468-rent-centerplus-3-on-improved-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3459468-rent-centerplus-3-on-improved-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459455\" data-ts=\"1557174637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459455-hertz-global-holdings-beats-0_36-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz Global Holdings beats by $0.36, misses on revenue</a></h4><ul><li>Hertz Global Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>): Q1 Non-GAAP EPS of -$0.99 <span style=\"color:green\">beats by $0.36</span>; GAAP EPS of -$1.75.</li><li>Revenue of $2.11B (+2.4% Y/Y) <font color=\"red\">misses by $10M</font>.</li><li>Shares <font color=\"green\">+3.14%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501020-hertz-global-holdings-reports-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459455\" data-linked=\"Hertz Global Holdings beats by $0.36, misses on revenue\" data-tweet=\"$HTZ - Hertz Global Holdings beats by $0.36, misses on revenue https://seekingalpha.com/news/3459455-hertz-global-holdings-beats-0_36-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459455-hertz-global-holdings-beats-0_36-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459454\" data-ts=\"1557174563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459454-teligent-misses-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teligent misses by $0.02, misses on revenue</a></h4><ul><li>Teligent (NASDAQ:<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>): Q1 Non-GAAP EPS of -$0.09 <span style=\"color:red\">misses by $0.02</span>; GAAP EPS of -$0.16.</li><li>Revenue of $13.12M (-9.8% Y/Y) <font color=\"red\">misses by $0.13M</font>.</li><li>Shares <font color=\"green\">+1.52%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501067-teligent-inc-announces-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459454\" data-linked=\"Teligent misses by $0.02, misses on revenue\" data-tweet=\"$TLGT - Teligent misses by $0.02, misses on revenue https://seekingalpha.com/news/3459454-teligent-misses-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459454-teligent-misses-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459443\" data-ts=\"1557174364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TACO\" target=\"_blank\">TACO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459443-margins-drop-del-taco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins drop at Del Taco</a></h4><ul> <li>Del Taco Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/TACO' title='Del Taco Restaurants, Inc.'>TACO</a>) reports comparable sales fell 0.1% in <a href=\"https://seekingalpha.com/pr/17500956-del-taco-restaurants-inc-reports-fiscal-first-quarter-2019-financial-results\" target=\"_blank\">Q1</a>.</li> <li>The company's restaurant contribution margin fell to 15.8% vs. 18.4% a year ago. An approximate 0.9% unfavorable impact from the adoption of the new lease accounting standard factored in.</li> <li>Looking ahead, Del Taco expects FY19 revenue of $517M to $527M vs. $517M consensus and EPS of $0.47 to $0.52 vs. $0.50 consensus.</li> <li>Shares of Del Taco are <font color=\"red\">down 3.42%</font> AH to $11.31.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459415-del-taco-restaurants-misses-0_02-revenue-line\" target=\"_blank\">Del Taco Restaurants misses by $0.02,  revenue in-line</a> (May 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459443\" data-linked=\"Margins drop at Del Taco\" data-tweet=\"$TACO - Margins drop at Del Taco https://seekingalpha.com/news/3459443-margins-drop-del-taco?source=tweet\" data-url=\"https://seekingalpha.com/news/3459443-margins-drop-del-taco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459423\" data-ts=\"1557174033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459423-gw-pharmas-epidiolex-successful-in-late-stage-study-in-another-rare-type-of-epilepsy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma&#39;s Epidiolex successful in late-stage study in another rare type of epilepsy</a></h4><ul><li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>) is up <font color=\"green\">4%</font> after hours on its <a href=\"https://seekingalpha.com/news/3459386-gw-pharma-q1-beat-propels-shares-4-percent-hours\" target=\"_blank\">Q1 beat</a> and on a successful <a href=\"https://seekingalpha.com/pr/17500914-gw-pharmaceuticals-reports-positive-phase-3-pivotal-trial-results-epidiolex-cannabidiol-oral\" target=\"_blank\">Phase 3 clinical trial</a> evaluating Epidiolex (cannabidiol) in patients with a rare and severe type of childhood epilepsy called tuberous sclerosis complex &#40;TSC&#41;.</li><li>The study met the primary endpoint of a statistically significant reduction in seizure frequency from baseline compared to placebo (p=0.0009). The company says this is the first pivotal study evaluating the 25 mg/kg/day and the 50 mg/kg/day doses.</li><li>It plans to file a supplemental marketing application in the U.S. in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459423\" data-linked=\"GW Pharma&#39;s Epidiolex successful in late-stage study in another rare type of epilepsy\" data-tweet=\"$GWPH - GW Pharma&#39;s Epidiolex successful in late-stage study in another rare type of epilepsy https://seekingalpha.com/news/3459423-gw-pharmas-epidiolex-successful-in-late-stage-study-in-another-rare-type-of-epilepsy?source=tweet\" data-url=\"https://seekingalpha.com/news/3459423-gw-pharmas-epidiolex-successful-in-late-stage-study-in-another-rare-type-of-epilepsy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459416\" data-ts=\"1557173917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459416-lannett-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lannett beats by $0.04, beats on revenue</a></h4><ul><li>Lannett (NYSE:<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a>): Q3 Non-GAAP EPS of $0.68 <span style=\"color:green\">beats by $0.04</span>; GAAP EPS of $0.27.</li><li>Revenue of $172.79M (-0.9% Y/Y) <font color=\"green\">beats by $17.24M</font>.</li><li>Shares <font color=\"green\">+9.03%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501071-lannett-announces-fiscal-2019-third-quarter-financial-results-raises-guidance-fiscal-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459416\" data-linked=\"Lannett beats by $0.04, beats on revenue\" data-tweet=\"$LCI - Lannett beats by $0.04, beats on revenue https://seekingalpha.com/news/3459416-lannett-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459416-lannett-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459412\" data-ts=\"1557173871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459412-hertzplus-5-on-bottom-line-surprise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz +5% on bottom line surprise</a></h4><ul> <li>Hertz Global Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) is on watch after posting a narrower-than-anticipated Q1 loss off in-line revenue of $2.11B.</li> <li>U.S. RAC total revenue up 7% during the quarter and transaction days were 4% higher.</li> <li>Shares of Hertz are <font color=\"green\">up 5.22%</font> AH to $20.66.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459412\" data-linked=\"Hertz +5% on bottom line surprise\" data-tweet=\"$HTZ - Hertz +5% on bottom line surprise https://seekingalpha.com/news/3459412-hertzplus-5-on-bottom-line-surprise?source=tweet\" data-url=\"https://seekingalpha.com/news/3459412-hertzplus-5-on-bottom-line-surprise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459409\" data-ts=\"1557173796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCMD\" target=\"_blank\">TCMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459409-tactile-systems-technology-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tactile Systems Technology beats by $0.14, beats on revenue</a></h4><ul><li>Tactile Systems Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/TCMD' title='Tactile Systems Technology, Inc.'>TCMD</a>): Q1 GAAP EPS of $0.08 <span style=\"color:green\">beats by $0.14</span>.</li><li>Revenue of $37.62M (+40.1% Y/Y) <font color=\"green\">beats by $4.32M</font>.</li><li>Shares <font color=\"green\">+4.34%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501003-tactile-systems-technology-inc-reports-first-quarter-2019-financial-results-updates-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459409\" data-linked=\"Tactile Systems Technology beats by $0.14, beats on revenue\" data-tweet=\"$TCMD - Tactile Systems Technology beats by $0.14, beats on revenue https://seekingalpha.com/news/3459409-tactile-systems-technology-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459409-tactile-systems-technology-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459405\" data-ts=\"1557173754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VECO\" target=\"_blank\">VECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459405-veeco-beats-q1-guides-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veeco beats Q1, guides in-line</a></h4><ul><li>Veeco Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a>) reports Q1 beats despite a 37% Y/Y revenue drop. The in-line Q2 outlook has revenue from $90-110M (consensus: $101M) and EPS of $(0.18)-0.02 (consensus: -$0.11).</li><li>Earnings call starts at 5:30 PM ET with a webcast <a href=\"http://ir.veeco.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17500994-veeco-reports-first-quarter-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459381-veeco-instruments-beats-0_07-beats-revenue\" target=\"_blank\">Veeco Instruments beats by $0.07, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459405\" data-linked=\"Veeco beats Q1, guides in-line\" data-tweet=\"$VECO - Veeco beats Q1, guides in-line https://seekingalpha.com/news/3459405-veeco-beats-q1-guides-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3459405-veeco-beats-q1-guides-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459386\" data-ts=\"1557173476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459386-gw-pharma-q1-beat-propels-shares-up-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma Q1 beat propels shares, up 4% after hours</a></h4><ul><li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>) <a href=\"https://seekingalpha.com/pr/17500919-gw-pharmaceuticals-plc-reports-financial-results-operational-progress-first-quarter-ended\" target=\"_blank\">Q1 results</a> ($M): Revenues: 39.2 (+999%); U.S. Epidiolex sales: 33.5.</li><li>Net loss: (50.1) (+27.9%); loss/share: (0.14) (+30.0%).</li><li>Cash flow ops: (58.4) (+10.7%).</li><li>Consensus view was a loss/share of ($2.53) on revenues of $16.5M.</li><li>The company also <a href=\"https://seekingalpha.com/pr/17500914-gw-pharmaceuticals-reports-positive-phase-3-pivotal-trial-results-epidiolex-cannabidiol-oral\" target=\"_blank\">reported </a>another successful late-stage study on Epidiolex, this time in tuberous sclerosis complex.</li><li>Shares are up <font color=\"green\">4%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459358-gw-pharmaceuticals-beats-0_07-beats-revenue\" target=\"_blank\">GW Pharmaceuticals beats by $0.07, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459386\" data-linked=\"GW Pharma Q1 beat propels shares, up 4% after hours\" data-tweet=\"$GWPH - GW Pharma Q1 beat propels shares, up 4% after hours https://seekingalpha.com/news/3459386-gw-pharma-q1-beat-propels-shares-up-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3459386-gw-pharma-q1-beat-propels-shares-up-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459377\" data-ts=\"1557173344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459377-therapeutics-md-beats-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapeutics MD beats by $0.01, misses on revenue</a></h4><ul><li>Therapeutics MD (NASDAQ:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD, Inc.'>TXMD</a>): Q1 GAAP EPS of -$0.16 <span style=\"color:green\">beats by $0.01</span>.</li><li>Revenue of $3.95M (+4.8% Y/Y) <font color=\"red\">misses by $2.01M</font>.</li><li>Shares <font color=\"green\">+1.98%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17500952-therapeuticsmd-announces-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459377\" data-linked=\"Therapeutics MD beats by $0.01, misses on revenue\" data-tweet=\"$TXMD - Therapeutics MD beats by $0.01, misses on revenue https://seekingalpha.com/news/3459377-therapeutics-md-beats-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459377-therapeutics-md-beats-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459374\" data-ts=\"1557173324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459374-biodelivery-sciences-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences beats by $0.03, beats on revenue</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>): Q1 GAAP EPS of -$0.05 <span style=\"color:green\">beats by $0.03</span>.</li><li>Revenue of $19.8M (+75.2% Y/Y) <font color=\"green\">beats by $0.27M</font>.</li><li>Shares <font color=\"green\">+1.4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17501002-biodelivery-sciences-reports-strong-first-quarter-2019-results-raises-belbuca-full-year\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459374\" data-linked=\"BioDelivery Sciences beats by $0.03, beats on revenue\" data-tweet=\"$BDSI - BioDelivery Sciences beats by $0.03, beats on revenue https://seekingalpha.com/news/3459374-biodelivery-sciences-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459374-biodelivery-sciences-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459358\" data-ts=\"1557173016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459358-gw-pharmaceuticals-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharmaceuticals beats by $0.07, beats on revenue</a></h4><ul><li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>): Q1 GAAP EPS of -$0.14 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $39.25M (+1191.1% Y/Y) <font color=\"green\">beats by $23.31M</font>.</li><li>Shares <font color=\"green\">+3.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17500919-gw-pharmaceuticals-plc-reports-financial-results-operational-progress-first-quarter-ended\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459358\" data-linked=\"GW Pharmaceuticals beats by $0.07, beats on revenue\" data-tweet=\"$GWPH - GW Pharmaceuticals beats by $0.07, beats on revenue https://seekingalpha.com/news/3459358-gw-pharmaceuticals-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3459358-gw-pharmaceuticals-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459344\" data-ts=\"1557171134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459344-suntrust-weighs-in-on-googles-criteo-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust weighs in on Google&#39;s Criteo impact</a></h4><ul><li>Google's <a href=\"https://seekingalpha.com/news/3459140-google-launch-privacy-tools-week-wsj\" target=\"_blank\">forthcoming</a> cookie-tracking tools are \"incremental negative\" for Criteo (<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='green'>+1.3%</font>) and less so for Rubicon (<a href='https://seekingalpha.com/symbol/RUBI' title='the Rubicon Project, Inc.'>RUBI</a> <font color='red'>-0.5%</font>), according to SunTrust.</li><li>Analyst Matthew Thornton: \"Conversely, if new tools are not turned on by default and are not easy to use or require multiple-steps, then this should be an incremental positive for CRTO and to a much much lesser extent RUBI.\"</li><li>He maintains a Hold rating and $24 PT on Criteo.</li><li>Other potentially impacted stocks: LiveRamp (<a href='https://seekingalpha.com/symbol/RAMP' title='LiveRamp Holdings, Inc.'>RAMP</a> <font color='red'>-0.7%</font>) and Trade Desk (<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a> <font color='red'>-2.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3459344\" data-linked=\"SunTrust weighs in on Google&#39;s Criteo impact\" data-tweet=\"$CRTO $RUBI $CRTO - SunTrust weighs in on Google&#39;s Criteo impact https://seekingalpha.com/news/3459344-suntrust-weighs-in-on-googles-criteo-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3459344-suntrust-weighs-in-on-googles-criteo-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459338\" data-ts=\"1557169330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459338-jks-teum-and-smi-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JKS, TEUM and SMI among tech movers</a></h4><ul><li><strong>Gainers: </strong>Sunworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a>) <font color=\"green\">+19%</font>. Bridgeline Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a>) <font color=\"green\">+18%</font>. Atomera Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Incorporated'>ATOM</a>) <font color=\"green\">+15%</font>. Digimarc Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DMRC' title='Digimarc Corporation'>DMRC</a>) <font color=\"green\">+12%</font>. Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"red\">-8%</font>. Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <font color=\"red\">-8%</font>. GSI Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/GSIT' title='GSI Technology, Inc.'>GSIT</a>) <font color=\"red\">-7%</font>. Semiconductor Manufacturing International (NYSE:<a href='https://seekingalpha.com/symbol/SMI' title='Semiconductor Manufacturing International Corporation'>SMI</a>) <font color=\"red\">-7%</font>. Alpha and Omega Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AOSL' title='Alpha and Omega Semiconductor Limited'>AOSL</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459338\" data-linked=\"JKS, TEUM and SMI among tech movers\" data-tweet=\"$SUNW $BLIN $ATOM - JKS, TEUM and SMI among tech movers https://seekingalpha.com/news/3459338-jks-teum-and-smi-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459338-jks-teum-and-smi-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459337\" data-ts=\"1557169289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459337-zillow-gains-after-valiant-capital-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow gains after Valiant Capital praise</a></h4><ul><li>Valiant Capital's Chris Hansen <a href=\"https://www.cnbc.com/2019/05/06/zillow-shares-rally-after-valiant-capitals-hansen-announces-position.html\" target=\"_blank\">names </a>Zillow (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color=\"green\">+3%</font>)(<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a> <font color=\"green\">+2.8%</font>) as one of his portfolio picks during the Sohn conference in New York.</li><li>Hansen says Zillow already has high-volume traffic coming into the site and will have another big rally after flexing its competitive advantage and move into the typical real estate commissions.</li><li>Hansen: \u201cWe think there\u2019s another big stair-step for this business coming.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3459337\" data-linked=\"Zillow gains after Valiant Capital praise\" data-tweet=\"$Z $ZG - Zillow gains after Valiant Capital praise https://seekingalpha.com/news/3459337-zillow-gains-after-valiant-capital-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3459337-zillow-gains-after-valiant-capital-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459334\" data-ts=\"1557168704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459334-facebook-updates-video-ranking-removes-russian-accounts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook updates video ranking; removes Russian accounts</a></h4><ul><li>Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a> <font color='red'>-0.7%</font>) <a href=\"https://newsroom.fb.com/news/2019/05/updates-to-video-ranking/\" target=\"_blank\">updates</a> the video ranks to prioritize \"1) loyalty and intent, 2) video and viewing durations and 3) originality.\"</li><li>The changes will affect video distribution across the Facebook platform from the News Feed to Facebook Watch.</li><li>In other news, FB <a href=\"https://newsroom.fb.com/news/2019/05/more-cib-from-russia/\" target=\"_blank\">reveals removing</a> 97 Facebook accounts, Pages and Groups that participated in coordinated inauthentic behavior as part of a Russian network that focused on Ukraine.</li><li>About 34K people followed one of the Pages and 86K joined at least one of the Groups.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459334\" data-linked=\"Facebook updates video ranking; removes Russian accounts\" data-tweet=\"$FB - Facebook updates video ranking; removes Russian accounts https://seekingalpha.com/news/3459334-facebook-updates-video-ranking-removes-russian-accounts?source=tweet\" data-url=\"https://seekingalpha.com/news/3459334-facebook-updates-video-ranking-removes-russian-accounts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459331\" data-ts=\"1557168166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEI\" target=\"_blank\">PEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459331-preit-gets-upgrade-hercules-gets-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PREIT gets an upgrade; Hercules gets cut</a></h4><ul><li>Pennsylvania REIT (NYSE:<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a>) <font color=\"green\">jumps 7.2%</font> after Boenning Scattergood <a href=\"https://www.americanbankingnews.com/2019/05/06/pennsylvania-r-e-i-t-pei-upgraded-to-outperform-at-boenning-scattergood.html\" target=\"_blank\">upgrades</a> the stock to outperform from neutral and ValuEngine changed its rating to sell from strong sell.</li><li>Hercules Capital (<a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a> <font color='green'>+0.4%</font>) <a href=\"https://www.americanbankingnews.com/2019/05/06/hercules-capital-htgc-stock-rating-lowered-by-wells-fargo-co.html\" target=\"_blank\">was cut</a> to market perform from outperform by Wells Fargo.</li><li>OFS Capital (<a href='https://seekingalpha.com/symbol/OFS' title='OFS Capital'>OFS</a> <font color='red'>-1%</font>) <a href=\"https://www.americanbankingnews.com/2019/05/06/ofs-capital-ofs-cut-to-neutral-at-ladenburg-thalm-sh-sh.html\" target=\"_blank\">was trimmed</a> to neutral from buy at Ladenburg Thalmann.</li><li>Santander Consumer USA (<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc.'>SC</a> <font color='red'>-0.7%</font>)<a href=\"https://www.americanbankingnews.com/2019/05/06/compass-point-downgrades-santander-consumer-usa-sc-to-neutral.html\" target=\"_blank\"> was also downgraded</a> to neutral from buy by Compass Point.</li><li>TriplePoint Venture Growth BDC (<a href='https://seekingalpha.com/symbol/TPVG' title='TriplePoint Venture Growth'>TPVG</a> <font color='red'>-1%</font>) <a href=\"https://www.marketbeat.com/stocks/NYSE/TPVG/price-target/\" target=\"_blank\">gets cut </a>to neutral from buy by Compass Point.</li><li>Deutsche Bank <a href=\"https://www.marketbeat.com/stocks/OTCMKTS/SSREY/price-target/\" target=\"_blank\">downgrades</a> Swiss Re (<a href='https://seekingalpha.com/symbol/SSREY' title='Swiss Re Ltd'>OTCPK:SSREY</a> <font color='red'>-2.1%</font>) to hold from buy.</li><li>Hovde Group<a href=\"https://www.americanbankingnews.com/2019/05/06/first-bank-frba-now-covered-by-analysts-at-hovde-group.html\" target=\"_blank\"> starts covering </a>First Bank (<a href='https://seekingalpha.com/symbol/FRBA' title='First Bank'>FRBA</a> <font color='red'>-0.2%</font>) with an outperform rating and a $13.00 price target.</li><li>SunTrust<a href=\"https://www.americanbankingnews.com/2019/05/06/suntrust-banks-initiates-coverage-on-pebblebrook-hotel-trust-peb.html\" target=\"_blank\"> initiates </a>Pebblebrook Hotel Trust (<a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color='red'>-0.3%</font>) at hold with a $43.00 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459331\" data-linked=\"PREIT gets an upgrade; Hercules gets cut\" data-tweet=\"$PEI $HTGC $OFS - PREIT gets an upgrade; Hercules gets cut https://seekingalpha.com/news/3459331-preit-gets-upgrade-hercules-gets-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3459331-preit-gets-upgrade-hercules-gets-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459330\" data-ts=\"1557167948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459330-buy-software-on-trade-sell-off-evercore\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buy software on trade sell-off - Evercore</a></h4><ul><li>Software stocks are feeling pressure from the increased US-China trade tensions even though most have little exposure to China.</li><li>For this reason, Evercore analyst Kirk Materne writes that the sell-off is a good time to buy.</li><li>S&amp;P 500 application software index is down 0.6% but dropped as much as 2.5% after President Trump threatened additional tariffs.</li><li>Decliners include Salesforce (<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a> <font color='red'>-0.8%</font>), Autodesk (<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color='red'>-1.3%</font>), Carbon Black (<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black, Inc.'>CBLK</a> <font color='red'>-2.7%</font>), Tableau (<a href='https://seekingalpha.com/symbol/DATA' title='Tableau Software, Inc.'>DATA</a> <font color='red'>-2%</font>), and Pluralsight (<a href='https://seekingalpha.com/symbol/PS' title='Pluralsight, Inc.'>PS</a> <font color='red'>-1.7%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459037-semis-slide-trumps-tariff-tweets\" target=\"_blank\">Semis could slide after Trump's tariff tweets</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459330\" data-linked=\"Buy software on trade sell-off - Evercore\" data-tweet=\"$CRM $ADSK $CBLK - Buy software on trade sell-off - Evercore https://seekingalpha.com/news/3459330-buy-software-on-trade-sell-off-evercore?source=tweet\" data-url=\"https://seekingalpha.com/news/3459330-buy-software-on-trade-sell-off-evercore\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459327\" data-ts=\"1557166909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSH\" target=\"_blank\">CTSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459327-cognizant-likely-cutting-indian-jobs-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognizant likely cutting Indian jobs - report</a></h4><ul><li>Cognizant (NASDAQ:<a href='https://seekingalpha.com/symbol/CTSH' title='Cognizant Technology Solutions Corporation'>CTSH</a>) might cut an unspecified number of jobs across multiple levels with mid-level the hardest hit, according to <em><a href=\"https://www.business-standard.com/article/companies/cognizant-may-cut-jobs-mostly-in-india-mid-level-staff-to-be-worst-hit-119050601392_1.html\" target=\"_blank\">Business Standard</a></em> sources.</li><li>Cognizant tells the publication it's \"currently evaluating various strategies, including additional employee separation programmes.\"</li><li>The company had 281,600 employees in 2018 with 70% working in India.</li><li>CTSH shares are <font color=\"green\">up 0.9%</font> to $59.81.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3458289-cognizant-minus-1_2-percent-slashed-fy-outlook\" target=\"_blank\">Cognizant -1.2% on slashed FY outlook</a> (May 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459327\" data-linked=\"Cognizant likely cutting Indian jobs - report\" data-tweet=\"$CTSH - Cognizant likely cutting Indian jobs - report https://seekingalpha.com/news/3459327-cognizant-likely-cutting-indian-jobs-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3459327-cognizant-likely-cutting-indian-jobs-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459323\" data-ts=\"1557166632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDW\" target=\"_blank\">TDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459323-tidewater-urged-activist-investor-to-tackle-challenges-faces\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tidewater urged by activist investor to &#39;tackle the challenges&#39; it faces</a></h4><ul><li>Activist shareholder Raging Capital <a href=\"https://www.sec.gov/Archives/edgar/data/98222/000092189519001275/ex991to13da207738094_050619.pdf\" target=\"_blank\">sends a letter</a> to Tidewater's (<a href='https://seekingalpha.com/symbol/TDW' title='Tidewater Inc.'>TDW</a> <font color=\"red\">-1.9%</font>) board expressing concerns about the company and urging immediate attention to \"tackle the challenges\" it faces.</li><li>Raging Capital, which owns ~7% of TDW shares, commends the company \"for its leading quality, scale and young age of its global fleet and its best-in-industry balance sheet\" but expresses several concerns it says the company \"must urgently address [to] capitalize on its enormous opportunities.\"</li><li>The hedge fund notes concerns about TDW's \"historic reputation as slow moving and bureaucratic, high G&amp;A costs per vessel, inefficiency of the current balance sheet structure, unwieldy board size, the board's lack of material ownership of the Issuer and the absence of a clear, incisive and focused short and long-term strategy.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3459323\" data-linked=\"Tidewater urged by activist investor to &#39;tackle the challenges&#39; it faces\" data-tweet=\"$TDW - Tidewater urged by activist investor to &#39;tackle the challenges&#39; it faces https://seekingalpha.com/news/3459323-tidewater-urged-activist-investor-to-tackle-challenges-faces?source=tweet\" data-url=\"https://seekingalpha.com/news/3459323-tidewater-urged-activist-investor-to-tackle-challenges-faces\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459314\" data-ts=\"1557166183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459314-tyson-gears-up-for-alternative-protein-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson gears up for alternative protein play</a></h4><ul> <li>Tyson (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods, Inc.'>TSN</a> <font color='green'>+2.3%</font>) is prepping to enter the alternative proteins space on a limited basis this summer and on a larger scale in the fall.</li> <li>\"We're well positioned to capture growth in this space. We have a deep understanding of how to develop new products, brands and categories, and our distribution reach will allow us to move quickly into the marketplace,\" said Tyson CEO Noel White on the earnings conference call this morning (<a href=\"https://seekingalpha.com/article/4260545-tyson-foods-inc-tsn-ceo-noel-white-q2-2019-results-earnings-call-transcript\" target=\"_blank\">transcript</a>).</li>   <li>Tyson backed out of its investment in Beyond Meat (<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a> <font color='green'>+5.5%</font>) just ahead of the disruptor's IPO due to its own meatless play. The rush by investors into Beyond Meat has pushed its market cap higher than that of Sanderson Farms (<a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a> <font color='green'>+0.8%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459314\" data-linked=\"Tyson gears up for alternative protein play\" data-tweet=\"$TSN $BYND $SAFM - Tyson gears up for alternative protein play https://seekingalpha.com/news/3459314-tyson-gears-up-for-alternative-protein-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3459314-tyson-gears-up-for-alternative-protein-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459302\" data-ts=\"1557165733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UHS\" target=\"_blank\">UHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459302-health-insurers-hospital-operators-in-green-bargain-hunters-move-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers/hospital operators in green as bargain hunters move in</a></h4><ul><li>Hospital operators, health insurers and managed care providers are, for the most part, bucking the broad market's down day as bargain hunters take advantage of the \"Medicare-for-All\"- stoked selloff, under the (correct) assumption that it has no chance of becoming law.</li><li>Selected tickers: Universal Health Services (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services, Inc.'>UHS</a> <font color=\"green\">+0.7%</font>); Surgery Partners (<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color=\"red\">-0.2%</font>); SunLink Health Systems (<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc.'>SSY</a> <font color=\"green\">+0.9%</font>); Select Medical Holdings (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color=\"green\">+2%</font>); Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color=\"green\">+1%</font>); Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"green\">+3.7%</font>); Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a>); HCA (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a> <font color=\"green\">+0.9%</font>); Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-0.2%</font>); eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"green\">+4.9%</font>); Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"green\">+11.8%</font>); WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"green\">+0.2%</font>); UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"green\">+1.4%</font>); Triple-S Management (<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color=\"green\">+0.4%</font>); Civitas Solutions (<a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a>); Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"green\">+2.4%</font>); Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"green\">+1.2%</font>); Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"green\">+1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459302\" data-linked=\"Health insurers/hospital operators in green as bargain hunters move in\" data-tweet=\"$UHS $SGRY $SSY - Health insurers/hospital operators in green as bargain hunters move in https://seekingalpha.com/news/3459302-health-insurers-hospital-operators-in-green-bargain-hunters-move-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3459302-health-insurers-hospital-operators-in-green-bargain-hunters-move-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459300\" data-ts=\"1557165678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459300-sanchez-midstream-partners-and-earthstone-energy-among-energy-materials-gainers-midstates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanchez Midstream Partners and Earthstone Energy among Energy/Materials gainers; Midstates Petroleum and Ossen Innovation among losers</a></h4><ul><li><b>Gainers: </b>Sanchez Midstream Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a>) <font color=\"green\">+12%</font>. Earthstone Energy (NYSE:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"green\">+9%</font>. Eldorado Gold (NYSE:<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>) <font color=\"green\">+7%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+6%</font>. Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Midstates Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/MPO' title='Midstates Petroleum Company, Inc.'>MPO</a>) <font color=\"red\">-16%</font>. Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"red\">-8%</font>. Foresight Energy (NYSE:<a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a>) <font color=\"red\">-7%</font>. Turquoise Hill Resources (NYSE:<a href='https://seekingalpha.com/symbol/TRQ' title='Turquoise Hill Resources Ltd.'>TRQ</a>) <font color=\"red\">-7%</font>. Aluminum Corporation of China (NYSE:<a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Limited'>ACH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459300\" data-linked=\"Sanchez Midstream Partners and Earthstone Energy among Energy/Materials gainers; Midstates Petroleum and Ossen Innovation among losers\" data-tweet=\"$SNMP $ESTE $EGO - Sanchez Midstream Partners and Earthstone Energy among Energy/Materials gainers; Midstates Petroleum and Ossen Innovation among losers https://seekingalpha.com/news/3459300-sanchez-midstream-partners-and-earthstone-energy-among-energy-materials-gainers-midstates?source=tweet\" data-url=\"https://seekingalpha.com/news/3459300-sanchez-midstream-partners-and-earthstone-energy-among-energy-materials-gainers-midstates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459272\" data-ts=\"1557163602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459272-alnylam-down-6-on-fda-ok-of-pfizers-tafamidis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam down 6% on FDA OK of Pfizer&#39;s tafamidis</a></h4><ul><li>Alnylam Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"red\">-5.5%</font>) slips on more than double normal volume in apparent reaction to the <a href=\"https://seekingalpha.com/news/3459009-fda-oks-two-oral-formulations-pfizers-tafamidis\" target=\"_blank\">FDA nod</a> for Pfizer's VYNDAQEL (tafamidis meglumine) and VYNDAMAX (tafamidis) for the treatment of cardiomyopathy associated with hereditary transthyretin-mediated amyloidosis (hATTR).</li><li>The FDA approved Alnylam's ONPATTRO (patisiran) in August 2018 for the treatment of polyneuropathy caused by hATTR. Many hATTR patients with polyneuropathy also have cardiomyopathy symptoms.</li><li>Related ticker: Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>)</li><li><strong>Update</strong>: Pfizer has priced VYNDAQEL/VYNDAMAX at $225K/year, well below ONPATTRO's $450K and Ionis Pharma's and Akcea Therapeutics Tegsedi, also at $450K.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459272\" data-linked=\"Alnylam down 6% on FDA OK of Pfizer&#39;s tafamidis\" data-tweet=\"$ALNY $IONS - Alnylam down 6% on FDA OK of Pfizer&#39;s tafamidis https://seekingalpha.com/news/3459272-alnylam-down-6-on-fda-ok-of-pfizers-tafamidis?source=tweet\" data-url=\"https://seekingalpha.com/news/3459272-alnylam-down-6-on-fda-ok-of-pfizers-tafamidis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459264\" data-ts=\"1557162511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459264-barclays-pulls-back-on-five-below\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays pulls back on Five Below</a></h4><ul> <li>Five Below (<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below, Inc.'>FIVE</a> <font color='red'>-2.9%</font>) falls after Barclays downgrades the retailer to an Equal Weight rating on a call tied to valuation.</li>  <li>\"Our new price target of $140 values FIVE at ~21x FY20 EV/EBITDA, which contemplates FIVE's continued emergence as one of the most attractive growth stories in retail, but at $140, we believe FIVE is fully valued therefore cannot warrant an Overweight rating,\" writes the Barclays analyst team.</li> <li>Shares of Five Below are up 98% over the last 52 weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459264\" data-linked=\"Barclays pulls back on Five Below\" data-tweet=\"$FIVE - Barclays pulls back on Five Below https://seekingalpha.com/news/3459264-barclays-pulls-back-on-five-below?source=tweet\" data-url=\"https://seekingalpha.com/news/3459264-barclays-pulls-back-on-five-below\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459255\" data-ts=\"1557162009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459255-intelligent-systems-leads-industrial-gainers-beazer-homes-usa-and-research-frontiers-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelligent Systems leads industrial gainers; Beazer Homes USA and Research Frontiers among losers</a></h4><ul><li><b>Gainers: </b>Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>) <font color=\"green\">+9%</font>. Coda Octopus Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CODA' title='Coda Octopus Group, Inc.'>CODA</a>) <font color=\"green\">+7%</font>. IntriCon (NASDAQ:<a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Twin Disc (NASDAQ:<a href='https://seekingalpha.com/symbol/TWIN' title='Twin Disc, Incorporated'>TWIN</a>) <font color=\"red\">-9%</font>. Research Frontiers (NASDAQ:<a href='https://seekingalpha.com/symbol/REFR' title='Research Frontiers Incorporated'>REFR</a>) <font color=\"red\">-6%</font>. Beazer Homes USA (NYSE:<a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a>) <font color=\"red\">-6%</font>. Preformed Line Products (NASDAQ:<a href='https://seekingalpha.com/symbol/PLPC' title='Preformed Line Products Company'>PLPC</a>) <font color=\"red\">-5%</font>. Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459255\" data-linked=\"Intelligent Systems leads industrial gainers; Beazer Homes USA and Research Frontiers among losers\" data-tweet=\"$INS $CODA $IIN - Intelligent Systems leads industrial gainers; Beazer Homes USA and Research Frontiers among losers https://seekingalpha.com/news/3459255-intelligent-systems-leads-industrial-gainers-beazer-homes-usa-and-research-frontiers-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3459255-intelligent-systems-leads-industrial-gainers-beazer-homes-usa-and-research-frontiers-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459259\" data-ts=\"1557161895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459259-fastenalminus-4-following-sales-slowdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal -4% following sales slowdown</a></h4><ul><li>Fastenal (NASDAQ:<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a>) plunges despite issuing <a href=\"https://investor.fastenal.com/static-files/a16fae91-300b-41d0-8b92-2dd3e5301b41\" target=\"_blank\">April sales data</a> which showed growth for the month rising at an apparently robust 12.5% Y/Y to $460.7M, the latest in a consistent string of 10%-15% gains.</li><li>April's performance looks to continue the positive growth trend, but this April included one more business day - 22 vs. 21- than the year ago period; adjusting for the difference, FAST daily sales growth was a more modest 7.4% Y/Y and actually declining 2.4% since last month after growing by 4.2% in March and 1.4% in February.</li><li>FAST also suffered a sharp dip in the number of top customers that are growing, with the percentage of top 100 national accounts exhibiting growth sliding to 70% from 82% in the year ago period and indicating a declining trend after the figure slipped from 88% in January to 77% in February and 78% in March.</li><li>The growth slowdown also could place FAST at risk of falling short of Q2 revenue expectations of $1.39B; to reach that mark, FAST will need to generate $936M more in revenue over the next two months, which would equate to 9% Y/Y growth.</li><li>Source: Briefing.com</li></ul><div class=\"tiny-share-widget\" data-id=\"3459259\" data-linked=\"Fastenal -4% following sales slowdown\" data-tweet=\"$FAST - Fastenal -4% following sales slowdown https://seekingalpha.com/news/3459259-fastenalminus-4-following-sales-slowdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3459259-fastenalminus-4-following-sales-slowdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459249\" data-ts=\"1557161796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459249-gwg-holdings-leads-financial-gainers-china-bat-group-and-senmiao-technology-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GWG Holdings leads financial gainers; China Bat Group and Senmiao Technology among losers</a></h4><ul><li><b>Gainers:</b> GWG Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings, Inc.'>GWGH</a>) <font color=\"green\">+17%</font>. Chesapeake Lodging Trust (NYSE:<a href='https://seekingalpha.com/symbol/CHSP' title='Chesapeake Lodging Trust'>CHSP</a>) <font color=\"green\">+7%</font>. Pennsylvania Real Estate Investment Trust (NYSE:<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a>) <font color=\"green\">+7%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Affiliated Managers Group (NYSE:<a href='https://seekingalpha.com/symbol/AMG' title='Affiliated Managers Group, Inc.'>AMG</a>) <font color=\"red\">-11%</font>. Kingstone Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/KINS' title='Kingstone Companies, Inc.'>KINS</a>) <font color=\"red\">-10%</font>. Senmiao Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology Limited'>AIHS</a>) <font color=\"red\">-6%</font>. China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"red\">-6%</font>. China Life Insurance (NYSE:<a href='https://seekingalpha.com/symbol/LFC' title='China Life Insurance Company Limited'>LFC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459249\" data-linked=\"GWG Holdings leads financial gainers; China Bat Group and Senmiao Technology among losers\" data-tweet=\"$GWGH $CHSP $PEI - GWG Holdings leads financial gainers; China Bat Group and Senmiao Technology among losers https://seekingalpha.com/news/3459249-gwg-holdings-leads-financial-gainers-china-bat-group-and-senmiao-technology-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459249-gwg-holdings-leads-financial-gainers-china-bat-group-and-senmiao-technology-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459247\" data-ts=\"1557161617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459247-sbgi-amg-giii-and-znh-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SBGI, AMG, GIII and ZNH among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Aquantia (NYSE:<a href='https://seekingalpha.com/symbol/AQ' title='Aquantia Corp.'>AQ</a>) <font color=\"green\">+36%</font>. Sinclair Broadcast (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) <font color=\"green\">+28%</font>. Athenex (NASDAQ:<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a>) <font color=\"green\">+25%</font>. Bridgeline Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a>) <font color=\"green\">+22%</font>. Regulus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics Inc.'>RGLS</a>) <font color=\"green\">+18%</font>. Ovid Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a>) <font color=\"green\">+17%</font>. Daxor Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corporation'>DXR</a>) <font color=\"green\">+17%</font>. Guardion Health Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GHSI' title='Guardion Health Sciences, Inc.'>GHSI</a>) <font color=\"green\">+16%</font>. ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"green\">+16%</font>. GWG Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings, Inc.'>GWGH</a>) <font color=\"green\">+16%</font>.</li> <li><strong>Losers: </strong>Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) <font color=\"red\">-57%</font>. Midstates Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/MPO' title='Midstates Petroleum Company, Inc.'>MPO</a>) <font color=\"red\">-16%</font>. Affiliated Managers Group (NYSE:<a href='https://seekingalpha.com/symbol/AMG' title='Affiliated Managers Group, Inc.'>AMG</a>) <font color=\"red\">-11%</font>. CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar, Inc.'>CWBR</a>) <font color=\"red\">-10%</font>. Research Frontiers (NASDAQ:<a href='https://seekingalpha.com/symbol/REFR' title='Research Frontiers Incorporated'>REFR</a>) <font color=\"red\">-10%</font>. China Southern Airlines Company (NYSE:<a href='https://seekingalpha.com/symbol/ZNH' title='China Southern Airlines Company Limited'>ZNH</a>) <font color=\"red\">-9%</font>. Twin Disc Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/TWIN' title='Twin Disc, Incorporated'>TWIN</a>) <font color=\"red\">-9%</font>. Ruhnn Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RUHN' title='Hangzhou Ruhnn Holding Co.,Ltd'>RUHN</a>) <font color=\"red\">-9%</font>. G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>) <font color=\"red\">-9%</font>. AAC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459247\" data-linked=\"SBGI, AMG, GIII and ZNH among notable midday movers\" data-tweet=\"$AQ $SBGI $ATNX - SBGI, AMG, GIII and ZNH among notable midday movers https://seekingalpha.com/news/3459247-sbgi-amg-giii-and-znh-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459247-sbgi-amg-giii-and-znh-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459200\" data-ts=\"1557160213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459200-neurocrines-opicapone-shows-positive-action-in-late-stage-parkinsons-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine&#39;s opicapone shows positive action in late-stage Parkinson&#39;s studies</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17499523-neurocrine-biosciences-presents-phase-iii-data-analysis-demonstrating-opicapone-added\" target=\"_blank\">Results </a>from two Phase 3 clinical trials evaluating Neurocrine Biosciences' (<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color=\"green\">+0.4%</font>) opicapone in Parkinson's disease &#40;PD&#41; patients showed a treatment effect. The data were presented at the American Academy of Neurology Annual Meeting in Philadelphia.</li><li>More than 60% of patients receiving a once-daily dose of 50 mg achieved at least a one-hour increase from baseline in total ON time at week 14/15 (an <a href=\"https://www.verywellhealth.com/on-off-phenomenon-2612093\" target=\"_blank\">ON period</a> is when the patient is able to move around more easily).</li><li>On the safety front, the most frequent treatment-related adverse event was dyskinesia (uncontrolled movements) (17.4%).</li><li>Opicapone inhibits an enzyme called catechol-O-methyltransferase that plays a key role in degrading molecules like dopamine. Inhibiting its action promotes higher levels of the neurotransmitter which improves PD symptoms (PD is caused by inadequate levels dopamine in the brain).</li><li>The company <a href=\"https://seekingalpha.com/news/3242351-neurocrine-bio-nabs-north-american-rights-pd-med-opicapone\" target=\"_blank\">in-licensed</a> North American rights from Portuguese drug maker BIAL in February 2017.</li><li>It was approved in Europe in June 2016, but is not yet commercially available in the U.S. or Canada.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459200\" data-linked=\"Neurocrine&#39;s opicapone shows positive action in late-stage Parkinson&#39;s studies\" data-tweet=\"$NBIX - Neurocrine&#39;s opicapone shows positive action in late-stage Parkinson&#39;s studies https://seekingalpha.com/news/3459200-neurocrines-opicapone-shows-positive-action-in-late-stage-parkinsons-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3459200-neurocrines-opicapone-shows-positive-action-in-late-stage-parkinsons-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459208\" data-ts=\"1557160081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459208-q1-earnings-sales-production-all-fall-sharply-endeavour-silver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Q1 earnings, sales, production all fall sharply at Endeavour Silver</a></h4><ul><li>Endeavour Silver (<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"red\">-2.3%</font>) slips after reporting a larger than expected <a href=\"https://seekingalpha.com/news/3458992-endeavour-silver-misses-0_07-beats-revenue\" target=\"_blank\">Q1 loss</a> amid sharp declines in revenue and production.</li><li>EXK swung to an adjusted net loss of $13.3M from a net $2.3M profit in the year-ago quarter, as revenue tumbled 28% while silver production sank 21% to 1.07M oz. and gold output declined 24% to 10K oz.</li><li>The company's average realized silver price in Q1 fell 7% Y/Y to $15.50/oz. sold and the average gold price slipped 1% to $1,315/oz., while all-in sustaining costs surged 37% to $19.37/oz. of silver, citing the weaker production and higher cash operating costs, inventory write-downs, employee severance payments, exploration and G&amp;A expenses.</li><li>EXK says Q1 was \"a challenging start to the year in operations, with no improvement of the systemic issues at Guanacevi and unexpected events such as the seven-week shut-down at El Compas due to a mill failure,\" and has  implemented several measures to conserve cash and turn around current performance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459208\" data-linked=\"Q1 earnings, sales, production all fall sharply at Endeavour Silver\" data-tweet=\"$EXK - Q1 earnings, sales, production all fall sharply at Endeavour Silver https://seekingalpha.com/news/3459208-q1-earnings-sales-production-all-fall-sharply-endeavour-silver?source=tweet\" data-url=\"https://seekingalpha.com/news/3459208-q1-earnings-sales-production-all-fall-sharply-endeavour-silver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459187\" data-ts=\"1557158698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DF\" target=\"_blank\">DF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459187-dean-foodsplus-10-amid-deal-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dean Foods +10% amid deal talk</a></h4><ul> <li>Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) is <font color=\"green\">up 9.7%</font> after <em>The Wall Street Journal</em> <a href=\"https://www.wsj.com/articles/dean-foods-falters-in-more-concentrated-milk-market-11557064801\" target=\"_blank\">reports</a> that the dairy company is focused on a restructuring or outright sale as part of a strategic review.</li> <li>Investors may be expecting an update from the company on the process when it reports earnings tomorrow.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3459187\" data-linked=\"Dean Foods +10% amid deal talk\" data-tweet=\"$DF - Dean Foods +10% amid deal talk https://seekingalpha.com/news/3459187-dean-foodsplus-10-amid-deal-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3459187-dean-foodsplus-10-amid-deal-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459184\" data-ts=\"1557158571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459184-avon-product-and-dean-foods-among-consumer-gainers-g-iii-apparel-group-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Product and Dean Foods among consumer gainers; G-III Apparel Group leads the losers</a></h4><ul><li><b>Gainers: </b>Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc'>BTN</a>) <font color=\"green\">+11%</font>. Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"green\">+10%</font>. Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+5%</font>. Clearwater Paper (NYSE:<a href='https://seekingalpha.com/symbol/CLW' title='Clearwater Paper Corporation'>CLW</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>) <font color=\"red\">-8%</font>. At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"red\">-6%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"red\">-5%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"red\">-5%</font>. Trinseo (NYSE:<a href='https://seekingalpha.com/symbol/TSE' title='Trinseo S.A.'>TSE</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459184\" data-linked=\"Avon Product and Dean Foods among consumer gainers; G-III Apparel Group leads the losers\" data-tweet=\"$BTN $DF $AVP - Avon Product and Dean Foods among consumer gainers; G-III Apparel Group leads the losers https://seekingalpha.com/news/3459184-avon-product-and-dean-foods-among-consumer-gainers-g-iii-apparel-group-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459184-avon-product-and-dean-foods-among-consumer-gainers-g-iii-apparel-group-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459182\" data-ts=\"1557158412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URGN\" target=\"_blank\">URGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459182-urogen-up-3-on-new-mitomycin-gel-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UroGen up 3% on new mitomycin gel data</a></h4><ul><li>Following up on its initial <a href=\"https://seekingalpha.com/news/3421373-urogens-ugnminus-101-shows-positive-action-late-stage-urothelial-cancer-study\" target=\"_blank\">announcement</a> of topline results in January, UroGen Pharma (<a href='https://seekingalpha.com/symbol/URGN' title='UroGen Pharma Ltd.'>URGN</a> <font color=\"green\">+3.4%</font>) <a href=\"https://seekingalpha.com/pr/17499546-urogen-delivers-updated-complete-response-cr-durability-data-ugnminus-101-phase-3-olympus\" target=\"_blank\">reports </a>findings from a secondary analysis from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02793128?lead=urogen&amp;rank=3\" target=\"_blank\">OLYMPUS </a>study of UGN-101 (mitomycin gel) for the non-surgical treatment of low-grade upper tract urothelial cancer (LGUTUC).</li><li>The overall complete response rate was 59% (n=42/71) as was a subset (n=20/34) of patients with endoscopically unresectable LGUTUC.</li><li>The durable (at least six months) complete response rates were 89% and 85%, respectively.</li><li>It rolling marketing application in the U.S. is in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459182\" data-linked=\"UroGen up 3% on new mitomycin gel data\" data-tweet=\"$URGN - UroGen up 3% on new mitomycin gel data https://seekingalpha.com/news/3459182-urogen-up-3-on-new-mitomycin-gel-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3459182-urogen-up-3-on-new-mitomycin-gel-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459178\" data-ts=\"1557157517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLK\" target=\"_blank\">XLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459178-semis-chinese-tech-drop-on-trade-tensions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis, Chinese tech drop on trade tensions</a></h4><ul><li>The Philadelphia Semiconductor Index is <font color=\"red\">down 2.4% </font>compared to the <font color=\"red\">1.3%</font> dip for the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) on the renewed US-China trade tensions after President Trump's weekend tariff tweets.</li><li>Semi index components taking hits include Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-3.7%</font>), Microchip Tech (<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a> <font color='red'>-3.8%</font>), Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a> <font color='red'>-3.5%</font>), AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-3.1%</font>), NXP Semi (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors N.V.'>NXPI</a> <font color='red'>-3%</font>), and Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-2.8%</font>).</li><li>Chinese tech names are also in the red, including Alibaba (<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='red'>-3.7%</font>), Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='red'>-1.6%</font>), JD.com (<a href='https://seekingalpha.com/symbol/JD' title='JD.com, Inc.'>JD</a> <font color='red'>-4.4%</font>), Qutoutiao (<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a> <font color='red'>-6.3%</font>), Sohu (<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Limited'>SOHU</a> <font color='red'>-4.7%</font>), and Uxin (<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a> <font color='red'>-4.3%</font>).</li><li>Related China tech ETFs: <a href='https://seekingalpha.com/symbol/KWEB' title='KraneShares CSI China Internet ETF'>KWEB</a>, <a href='https://seekingalpha.com/symbol/CQQQ' title='Invesco China Technology ETF'>CQQQ</a>, <a href='https://seekingalpha.com/symbol/QQQC-OLD' title='Global X China Technology ETF'>QQQC-OLD</a>, <a href='https://seekingalpha.com/symbol/CWEB' title='Direxion Daily CSI China Internet Index Bull 2x Shares ETF'>CWEB</a>, <a href='https://seekingalpha.com/symbol/CHIK' title='Global X MSCI China Information Technology ETF'>CHIK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459178\" data-linked=\"Semis, Chinese tech drop on trade tensions\" data-tweet=\"$XLK $SOXX $XLK - Semis, Chinese tech drop on trade tensions https://seekingalpha.com/news/3459178-semis-chinese-tech-drop-on-trade-tensions?source=tweet\" data-url=\"https://seekingalpha.com/news/3459178-semis-chinese-tech-drop-on-trade-tensions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>121&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459172\" data-ts=\"1557157148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLS\" target=\"_blank\">RGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459172-regulus-up-12-on-improved-finances\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulus up 12% on improved finances</a></h4><ul><li>Thinly traded nano cap Regulus Therapeutics (<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics Inc.'>RGLS</a> <font color=\"green\">+11.9%</font>) is up on below-average volume on the heels of recent financing developments.</li><li>It will <a href=\"https://seekingalpha.com/pr/17500317-regulus-therapeutics-announces-private-placement-equity\" target=\"_blank\">sell stock and warrants</a> totaling ~$41.8M in a two-tranche private placement with institutional investors. The initial tranche, valued at ~$16.7M, consists of ~9.7M common shares and accompanying warrants at a combined price of $1.205. Certain investors have also agreed to 416K share of non-voting Class A-1 convertible preferred stock, each convertible into 10 common shares, at $10.80 per share along with five-year warrants to buy up to ~4.16M common shares at $1.08 per share at $0.125 per warrant. The transaction should close no later than May 7.</li><li>The second tranche of ~$25.1M of convertible preferred stock and accompanying warrants will be contingent on the restart of a Phase 1 study of RGLS4326 in autosomal-dominant polycystic kidney disease.</li><li>It has <a href=\"https://seekingalpha.com/pr/17500378-regulus-therapeutics-announces-restructuring-term-loan\" target=\"_blank\">restructured </a>its $14.7M term loan with Oxford Finance providing for a new 12-month period of interest-only payments and a new maturity date of May 2022.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459172\" data-linked=\"Regulus up 12% on improved finances\" data-tweet=\"$RGLS - Regulus up 12% on improved finances https://seekingalpha.com/news/3459172-regulus-up-12-on-improved-finances?source=tweet\" data-url=\"https://seekingalpha.com/news/3459172-regulus-up-12-on-improved-finances\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459167\" data-ts=\"1557156658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLL\" target=\"_blank\">FLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459167-full-house-resortsminus-8-after-eps-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Full House Resorts -8% after EPS miss</a></h4><ul> <li>Full House Resorts (<a href='https://seekingalpha.com/symbol/FLL' title='Full House Resorts, Inc.'>FLL</a> <font color='red'>-8%</font>) reports adjusted EBITDA rose 20% in <a href=\"https://seekingalpha.com/pr/17500036-full-house-resorts-announces-first-quarter-results\" target=\"_blank\">Q1</a> to $3.6M on operating efficiencies and improved weather at Silver Slipper. Adjusted EBITDA was down at Rising Star Casino, due in part to flooding and other adverse weather.</li> <li>The casino operator expects legislative changes in Indiana, including the introduction of sports betting in the near term and a reduction in the tax rate on Rising Star's casino revenues effective in mid-2021, to benefit the property over the long-term.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459055-full-house-resorts-misses-0_07-beats-revenue\" target=\"_blank\">Full House Resorts misses by $0.07, beats on revenue</a> (May 6)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3459167\" data-linked=\"Full House Resorts -8% after EPS miss\" data-tweet=\"$FLL - Full House Resorts -8% after EPS miss https://seekingalpha.com/news/3459167-full-house-resortsminus-8-after-eps-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3459167-full-house-resortsminus-8-after-eps-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459164\" data-ts=\"1557156479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459164-deere-caterpillar-tumble-on-trump-trade-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere, Caterpillar tumble on Trump trade threat</a></h4><ul><li>Industrial companies and metals producers reliant on Chinese demand bounce off opening losses but <a href=\"https://www.wsj.com/articles/tech-industrial-stocks-slide-on-renewed-trade-fears-11557154734\" target=\"_blank\">remain sharply lower</a> following Pres. Trump's latest tariff threat.</li><li>Among major industrial names: <a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color=\"red\">-3.8%</font>, <a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color=\"red\">-1.8%</font>, <a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color=\"red\">-1.7%</font>, <a href='https://seekingalpha.com/symbol/FLR' title='Fluor Corporation'>FLR</a> <font color=\"red\">-0.9%</font>, <a href='https://seekingalpha.com/symbol/HON' title='Honeywell International Inc.'>HON</a> <font color=\"red\">-0.3%</font>.</li><li>Copper producer Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"red\">-2.1%</font>) also slid, as the metal some analysts use to gauge economic activity because of its widespread applications extends a recent pullback.</li><li>Also: <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color=\"red\">-2.8%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color=\"red\">-2.2%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Group'>BHP</a> <font color=\"red\">-1.7%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto Group'>RIO</a> <font color=\"red\">-1.5%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color=\"red\">-1.4%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a> <font color=\"red\">-0.6%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color=\"red\">-0.5%</font>.</li><li>Other relevant tickers include <a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>, <a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore plc'>OTCPK:GLNCY</a>, <a href='https://seekingalpha.com/symbol/FSUMF' title='Fortescue Metals Group Limited'>OTCQX:FSUMF</a></li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLB' title='Materials Select Sector SPDR ETF'>XLB</a>, <a href='https://seekingalpha.com/symbol/JJCTF' title='iPath DJ-UBS Copper Total Return Sub-Index ETN'>OTCPK:JJCTF</a>, <a href='https://seekingalpha.com/symbol/BCX' title='BlackRock Resources&Commodities Strategy Trust'>BCX</a>, <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>, <a href='https://seekingalpha.com/symbol/PEO' title='Adams Natural Resources Fund, Inc.'>PEO</a>, <a href='https://seekingalpha.com/symbol/VAW' title='Vanguard Materials ETF'>VAW</a>, <a href='https://seekingalpha.com/symbol/COPX' title='Global X Copper Miners ETF'>COPX</a>, <a href='https://seekingalpha.com/symbol/DBB' title='Invesco DB Base Metals ETF'>DBB</a>, <a href='https://seekingalpha.com/symbol/UYM' title='ProShares Ultra Basic Materials ETF'>UYM</a>, <a href='https://seekingalpha.com/symbol/IYM' title='iShares U.S. Basic Materials ETF'>IYM</a>, <a href='https://seekingalpha.com/symbol/JJN' title='iPath DJ-UBS Nickel Total Return Sub-Index ETN'>JJN</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/GNR' title='SPDR S&P Global Natural Resources ETF'>GNR</a>, <a href='https://seekingalpha.com/symbol/HAP' title='VanEck Vectors Natural Resources ETF'>HAP</a>, <a href='https://seekingalpha.com/symbol/FMAT' title='Fidelity MSCI Materials Index ETF'>FMAT</a>, <a href='https://seekingalpha.com/symbol/MXI' title='iShares Global Materials ETF'>MXI</a>, <a href='https://seekingalpha.com/symbol/SMN' title='ProShares UltraShort Basic Materials ETF'>SMN</a>, <a href='https://seekingalpha.com/symbol/GUNR' title='FlexShares Morningstar Global Upstream Natural Resources Index ETF'>GUNR</a>, <a href='https://seekingalpha.com/symbol/BOM' title='DB Base Metals Double Short ETN'>BOM</a>, <a href='https://seekingalpha.com/symbol/FXZ' title='First Trust Materials AlphaDEX ETF'>FXZ</a>, <a href='https://seekingalpha.com/symbol/BDD' title='DB Base Metals Double Long ETN'>BDD</a>, <a href='https://seekingalpha.com/symbol/JJT-OLD' title='iPath Dow Jones-UBS Tin Total Return Sub-Index ETN'>JJT-OLD</a>, <a href='https://seekingalpha.com/symbol/RTM' title='Invesco S&P Equal Weight Materials ETF'>RTM</a>, <a href='https://seekingalpha.com/symbol/JJM' title='iPath DJ-UBS Industrial Metals Total Return Sub-Index ETN'>JJM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3459164\" data-linked=\"Deere, Caterpillar tumble on Trump trade threat\" data-tweet=\"$DE $DWDP $CAT - Deere, Caterpillar tumble on Trump trade threat https://seekingalpha.com/news/3459164-deere-caterpillar-tumble-on-trump-trade-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3459164-deere-caterpillar-tumble-on-trump-trade-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459153\" data-ts=\"1557155742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459153-ligand-nabs-economic-rights-to-skin-infection-candidate-from-novan-for-up-to-32m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand nabs economic rights to skin infection candidate from Novan for up to $32M</a></h4><ul><li>Ligand Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color=\"green\">+1.1%</font>) has <a href=\"https://seekingalpha.com/pr/17500249-ligand-acquires-milestone-royalty-rights-sb206-novan-inc\" target=\"_blank\">acquired </a>the economic rights to Novan's (<a href='https://seekingalpha.com/symbol/NOVN' title='Novan, Inc.'>NOVN</a> <font color=\"red\">-0.5%</font>) SB206, a topical antiviral gel in Phase 3 development for skin infections, for $12M in upfront cash, up to $20M in milestones and tiered royalties of 7 - 10%.</li><li>Novan will be responsible for all development and commercialization expenses and will use the proceeds from this transaction to advance the candidate through the registration process.</li><li>If all goes well, commercial launch should happen in 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459153\" data-linked=\"Ligand nabs economic rights to skin infection candidate from Novan for up to $32M\" data-tweet=\"$LGND $NOVN - Ligand nabs economic rights to skin infection candidate from Novan for up to $32M https://seekingalpha.com/news/3459153-ligand-nabs-economic-rights-to-skin-infection-candidate-from-novan-for-up-to-32m?source=tweet\" data-url=\"https://seekingalpha.com/news/3459153-ligand-nabs-economic-rights-to-skin-infection-candidate-from-novan-for-up-to-32m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459152\" data-ts=\"1557155621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459152-trade-jitters-hit-apparel-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade jitters hit the apparel sector</a></h4><ul> <li>Select apparel stocks are down sharply as investors add back in some risk of an escalating U.S.-China trade war.</li> <li>Notable decliners in morning trading include G-III Apparel (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>)<font color=\"red\"> -5.8%</font>, Canada Goose (NYSE:<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings Inc.'>GOOS</a>) <font color=\"red\">-4.6%</font>, Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess&#39;, Inc.'>GES</a>) <font color=\"red\">-3.9%</font>, Crocs (NASDAQ:<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a>) <font color=\"red\">-3.5%</font>, Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers U.S.A., Inc.'>SKX</a>) <font color=\"red\">-3.4%</font>, Tailored Brands (NYSE:<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc.'>TLRD</a>) <font color=\"red\">-3.3%</font>, Steven Madden (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOO' title='Steven Madden, Ltd.'>SHOO</a>) <font color=\"red\">-3.3%</font>, Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a>) <font color=\"red\">-3.1%</font>, Carter's (NYSE:<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a>) <font color=\"red\">-3.1%</font>, Children's Place (NASDAQ:<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place, Inc.'>PLCE</a>) <font color=\"red\">-3.0%</font>, Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a>) <font color=\"red\">-2.7%</font>, Under Armour (NYSE:<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) <font color=\"red\">-2.6%</font>, Ralph Lauren (NYSE:<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a>) <font color=\"red\">-2.5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3459152\" data-linked=\"Trade jitters hit the apparel sector\" data-tweet=\"$GIII $GOOS $GES - Trade jitters hit the apparel sector https://seekingalpha.com/news/3459152-trade-jitters-hit-apparel-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3459152-trade-jitters-hit-apparel-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459150\" data-ts=\"1557155251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459150-stocks-bounce-from-worst-levels\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks bounce from worst levels</a></h4><ul><li>All three of the major averages have trimmed their losses to <font color=\"red\">less than 1%</font> on the session. All S&amp;P 500 sectors remain in the red.</li><li>Also well off the lows is crude oil, which nearly dropped below $60 per barrel in panicky overnight action, but is now up to $61.61, <font color=\"red\">down just $0.35</font> for the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459150\" data-linked=\"Stocks bounce from worst levels\" data-tweet=\"Stocks bounce from worst levels https://seekingalpha.com/news/3459150-stocks-bounce-from-worst-levels?source=tweet\" data-url=\"https://seekingalpha.com/news/3459150-stocks-bounce-from-worst-levels\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459149\" data-ts=\"1557155153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PD\" target=\"_blank\">PD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459149-pagerdutyplus-2_4-on-two-overweight-starts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PagerDuty +2.4% on two Overweight starts</a></h4><ul><li>Piper Jaffray starts Pagerduty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) at Overweight with a $52 PT citing \u201ca large TAM, clear and tangible value proposition, and favorable competitive dynamics can drive sustained 40%+ revenue growth.\"</li><li>The firm says PD would be a \"highly strategic asset\" for the likes of ServiceNow, Microsoft, Alphabet, Cisco, and VMware.</li><li>William Blair starts PD at Overweight and sees the potential for more than $20B in spending on operations platforms for digital businesses, which gives PagerDuty room for sustained 20%+ growth for several years.</li><li>PD shares are <font color=\"green\">up 2.4%</font> to $47.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459149\" data-linked=\"PagerDuty +2.4% on two Overweight starts\" data-tweet=\"$PD - PagerDuty +2.4% on two Overweight starts https://seekingalpha.com/news/3459149-pagerdutyplus-2_4-on-two-overweight-starts?source=tweet\" data-url=\"https://seekingalpha.com/news/3459149-pagerdutyplus-2_4-on-two-overweight-starts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459148\" data-ts=\"1557155130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459148-immunogen-and-athenex-among-healthcare-gainers-aac-holdings-and-petmed-express-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers</a></h4><ul><li><b>Gainers: </b>Athenex (NASDAQ:<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a>) <font color=\"green\">+22%</font>. Ovid Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a>) <font color=\"green\">+16%</font>. Daxor (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corporation'>DXR</a>) <font color=\"green\">+16%</font>. ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"green\">+16%</font>.  Guardion Health Science (NASDAQ:<a href='https://seekingalpha.com/symbol/GHSI' title='Guardion Health Sciences, Inc.'>GHSI</a>)<font color=\"green\"> +10%.</font></li><li><b>Losers: </b>CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar, Inc.'>CWBR</a>) <font color=\"red\">-9%</font>. Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"red\">-8%</font>. AAC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) <font color=\"red\">-8%</font>. PetMed Express (NASDAQ:<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a>) <font color=\"red\">-8%</font>. NGM Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/NGM' title='NGM Biopharmaceuticals, Inc.'>NGM</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459148\" data-linked=\"ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers\" data-tweet=\"$ATNX $OVID $DXR - ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers https://seekingalpha.com/news/3459148-immunogen-and-athenex-among-healthcare-gainers-aac-holdings-and-petmed-express-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3459148-immunogen-and-athenex-among-healthcare-gainers-aac-holdings-and-petmed-express-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459146\" data-ts=\"1557154958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNX\" target=\"_blank\">ATNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459146-athenex-up-24-on-100m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenex up 24% on $100M capital raise</a></h4><ul><li>Athenex (<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a> <font color=\"green\">+24%</font>) is up on more than double normal volume in reaction to its <a href=\"https://seekingalpha.com/pr/17500024-athenex-announces-100-million-private-placement\" target=\"_blank\">$100M private placement</a> of stock with three institutional investors. Specifically, the company will issue 10M common shares at $10 per share. The transaction should close by May 7.</li><li>Friday's close was $10.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459146\" data-linked=\"Athenex up 24% on $100M capital raise\" data-tweet=\"$ATNX - Athenex up 24% on $100M capital raise https://seekingalpha.com/news/3459146-athenex-up-24-on-100m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3459146-athenex-up-24-on-100m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459140\" data-ts=\"1557153216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459140-google-launch-privacy-tools-this-week-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google could launch privacy tools this week - WSJ</a></h4><ul><li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='red'>-0.3%</font>) could launch its new privacy tools limiting the use of tracking cookies as early as this week, according to <a href=\"https://www.wsj.com/articles/googles-new-privacy-tools-to-make-cookies-crumble-competitors-stumble-11557151913\" target=\"_blank\">WSJ sources</a>.</li><li>The rollout will give Chrome a dashboard-like function that shows users what cookies are tracking them and offers to block the tracking.</li><li>Apple's Safari and Mozilla's Firefox have similar though more stringent tracking blocks in place.</li><li>The changes aren't expected to impact Google's ability to collect data for ads.</li><li>Shares of Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>), which helps sites attach cookies to visitors, are up 2.3%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459140\" data-linked=\"Google could launch privacy tools this week - WSJ\" data-tweet=\"$GOOG $GOOGL $CRTO - Google could launch privacy tools this week - WSJ https://seekingalpha.com/news/3459140-google-launch-privacy-tools-this-week-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3459140-google-launch-privacy-tools-this-week-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459138\" data-ts=\"1557152880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459138-can-fite-readies-late-stage-study-of-namodenoson-in-liver-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite readies late-stage study of Namodenoson in liver cancer</a></h4><ul><li>Can-Fite BioPharma (<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a> <font color=\"green\">+0.7%</font>) is <a href=\"https://seekingalpha.com/pr/17499737-can-fite-announces-preparation-end-phase-ii-meeting-fda-initiate-phase-iii-liver-cancer-study\" target=\"_blank\">preparing </a>a pivotal Phase 3 clinical trial assessing Namodenoson for the treatment of liver cancer in both first-line and second-line settings.</li><li>A Phase 2 study was <a href=\"https://seekingalpha.com/news/3445755-can-fites-namodenoson-flunks-mid-stage-liver-cancer-study-shares-26-percent\" target=\"_blank\">unsuccessful</a>, but an increase in overall survival was observed in a subpopulation of patients with <a href=\"https://www.2minutemedicine.com/the-child-pugh-score-prognosis-in-chronic-liver-disease-and-cirrhosis-classics-series/\" target=\"_blank\">Child Pugh B7</a> (mid-level in severity) hepatocellular carcinoma.</li><li>Namodenoson is an orally available small molecule that binds with high affinity and selectivity to the A3 adenosine receptor (A3AR), highly expressed in diseased cells compared to low expression in normal cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459138\" data-linked=\"Can-Fite readies late-stage study of Namodenoson in liver cancer\" data-tweet=\"$CANF - Can-Fite readies late-stage study of Namodenoson in liver cancer https://seekingalpha.com/news/3459138-can-fite-readies-late-stage-study-of-namodenoson-in-liver-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3459138-can-fite-readies-late-stage-study-of-namodenoson-in-liver-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459137\" data-ts=\"1557152511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWIN\" target=\"_blank\">TWIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459137-twin-disc-slips-8-post-q3-results-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twin Disc slips 8% post Q3 results miss</a></h4><ul><li>Twin Disc (<a href='https://seekingalpha.com/symbol/TWIN' title='Twin Disc, Incorporated'>TWIN</a> <font color=\"red\">-8.3%</font>) reported Q3 net sales growth of 18.5% Y/Y to $77.42M, includes benefits of the Veth Propulsion acquisition.</li><li>Q3 Gross margin <font color=\"red\">declined by 200 bps</font> to 29.8%, due to a less profitable mix of revenues and reduced operating efficiencies.</li><li>Q3 EBITDA was $9.96M (+30.1% Y/Y), and margin i<font color=\"green\">mproved by 191 bps </font>to 12.9%.</li><li>Net cash used in operating activities YTD was $ $12.16M, compare to $1M provided a year ago.</li><li>Company completed sales of Mill Log for ~$7.66M during the quarter.</li><li>Company had cash of $15.17M as of March 29, 2019.</li><li>Twin Disc\u2019s six-month backlog at March 29, 2019, was ~$113.7M, (includes the contribution of Veth Propulsion acquisition), compared to ~$116.12M a year ago.</li><li>Company says significant supply chain challenges contributed to reduced efficiencies and impacted shipments during Q3.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459058-twin-disc-misses-0_07-misses-revenue\" target=\"_blank\">Twin Disc misses by $0.07, misses on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459137\" data-linked=\"Twin Disc slips 8% post Q3 results miss\" data-tweet=\"$TWIN - Twin Disc slips 8% post Q3 results miss https://seekingalpha.com/news/3459137-twin-disc-slips-8-post-q3-results-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3459137-twin-disc-slips-8-post-q3-results-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459134\" data-ts=\"1557152182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459134-chinese-airline-stocks-clipped-trade-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese airline stocks clipped by trade news</a></h4><ul> <li>China Southern Airlines (<a href='https://seekingalpha.com/symbol/ZNH' title='China Southern Airlines Company Limited'>ZNH</a> <font color='red'>-10.5%</font>) and China Eastern Airlines (<a href='https://seekingalpha.com/symbol/CEA' title='China Eastern Airlines Corporation Limited'>CEA</a> <font color='red'>-9.2%</font>) fall sharply on concerns the U.S.-China trade battle will extend.</li> <li>Both stocks were up more than 25% YTD before today on hopes that a trade deal was imminent.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3459134\" data-linked=\"Chinese airline stocks clipped by trade news\" data-tweet=\"$ZNH $CEA - Chinese airline stocks clipped by trade news https://seekingalpha.com/news/3459134-chinese-airline-stocks-clipped-trade-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3459134-chinese-airline-stocks-clipped-trade-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459132\" data-ts=\"1557151783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459132-chemours-price-target-lowered-rbc-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemours price target lowered at RBC Capital</a></h4><ul><li>Following its Q1 earnings miss and \"slightly bearish\" outlook, RBC Capital has lowered its price target on Chemours (<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color=\"red\">-3.9%</font>) to $43 from $50.</li><li>The firm also cautioned that its Fluoroproducts segment could continue to underperform in Q2 despite a better forecast.</li><li>RBC maintained its Outperform rating on shares, however, saying titanium dioxide volumes could improve later in 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459132\" data-linked=\"Chemours price target lowered at RBC Capital\" data-tweet=\"$CC - Chemours price target lowered at RBC Capital https://seekingalpha.com/news/3459132-chemours-price-target-lowered-rbc-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3459132-chemours-price-target-lowered-rbc-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459130\" data-ts=\"1557151751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UROV\" target=\"_blank\">UROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459130-urovant-up-5-on-successful-late-stage-vibegron-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urovant up 5% on successful late-stage vibegron studies</a></h4><ul><li>Thinly traded micro cap Urovant Sciences (<a href='https://seekingalpha.com/symbol/UROV' title='Urovant Sciences Ltd.'>UROV</a> <font color=\"green\">+5.1%</font>) bucks the broad market selloff, albeit on light volume. <a href=\"https://seekingalpha.com/pr/17499902-urovant-sciences-presents-positive-pivotal-data-vibegron-plenary-session-american-urological\" target=\"_blank\">Detailed results</a> from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03583372?lead=urovant&amp;rank=3\" target=\"_blank\">EMPOWUR </a>study assessing vibegron in overactive bladder patients were presented yesterday at the American Urological Association Annual Meeting in Chicago. The company first <a href=\"https://seekingalpha.com/news/3443984-urovant-9-percent-premarket-positive-vibregon-data\" target=\"_blank\">announced </a>the successful outcome in March.</li><li>The study showed that treatment with vibegron, a once-daily oral beta-3 adrenergic agonist, produced statistically significant reductions in daily urge urinary incontinence episodes and daily micturitions (passing urine) compared to placebo. The treatment effects were observed as early as the second week.</li><li>All key secondary endpoints were also met.</li><li>A generic alternative called tolterodine may be a viable competitor, however.</li><li>The company says it expects to file a U.S. marketing application no later than early Q1 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459130\" data-linked=\"Urovant up 5% on successful late-stage vibegron studies\" data-tweet=\"$UROV - Urovant up 5% on successful late-stage vibegron studies https://seekingalpha.com/news/3459130-urovant-up-5-on-successful-late-stage-vibegron-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3459130-urovant-up-5-on-successful-late-stage-vibegron-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459129\" data-ts=\"1557151419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459129-sysco-up-after-showing-margin-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sysco up after showing margin improvement</a></h4><ul> <li>Sysco (<a href='https://seekingalpha.com/symbol/SYY' title='Sysco Corporation'>SYY</a> <font color='green'>+2.1%</font>) trades higher after posting a mixed <a href=\"https://seekingalpha.com/pr/17500035-sysco-reports-third-quarter-fiscal-2019-results\" target=\"_blank\">FQ3</a> report.</li> <li>Total case volume was up 2.1% during the quarter. Organic case volume was 1.3% higher.</li> <li>Gross margin was up 14 bps Y/Y to 18.8% of sales vs. 18.7% consensus.</li> <li>Operating margin was 4.2% of sales vs. 3.9% consensus.</li> <li>\"Our continued focus on profitable growth and supporting our customers at a high level, balanced with managing expenses well, allowed us to deliver solid operating income growth this quarter,\" says Sysco CEO Tom Bene.</li> <li>Shares of Sysco are up 15% YTD.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459048-sysco-beats-0_09-misses-revenue\" target=\"_blank\">Sysco beats by $0.09, misses on revenue</a> (May 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3459129\" data-linked=\"Sysco up after showing margin improvement\" data-tweet=\"$SYY - Sysco up after showing margin improvement https://seekingalpha.com/news/3459129-sysco-up-after-showing-margin-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3459129-sysco-up-after-showing-margin-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459125\" data-ts=\"1557151279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459125-anadarko-likely-to-deem-oxys-offer-superior-to-chevrons-today-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko likely to deem OXY&#39;s offer superior to Chevron&#39;s today - CNBC</a></h4><ul><li>Anadarko Petroleum's (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+3.1%</font>) board of directors likely will determine today that Occidental Petroleum's (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color=\"green\">+0.5%</font>) <a href=\"https://www.cnbc.com/2019/05/06/anadarko-is-likely-to-deem-occidentals-buyout-offer-superior-to-chevrons-bid-sources.html\" target=\"_blank\">revised buyout offer is superior</a> to Chevron's (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+1.5%</font>) buyout agreement reached last month, CNBC's David Faber reports.</li><li>OXY has taken several steps to outmatch CVX since launching its own offer nearly two weeks ago, and this weekend <a href=\"https://seekingalpha.com/news/3459011-occidental-raises-cash-offer-anadarko\" target=\"_blank\">increased the cash portion</a> of its bid to 78% cash compared to its earlier 50-50 cash-and-stock proposal.</li><li>Raising the cash component means OXY would not have  to hold a shareholder vote on the acquisition, making it more likely it could complete the deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3459125\" data-linked=\"Anadarko likely to deem OXY&#39;s offer superior to Chevron&#39;s today - CNBC\" data-tweet=\"$APC $OXY $CVX - Anadarko likely to deem OXY&#39;s offer superior to Chevron&#39;s today - CNBC https://seekingalpha.com/news/3459125-anadarko-likely-to-deem-oxys-offer-superior-to-chevrons-today-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3459125-anadarko-likely-to-deem-oxys-offer-superior-to-chevrons-today-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459123\" data-ts=\"1557150554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSSC\" target=\"_blank\">NSSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459123-strong-margins-for-napco-security-technologies-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong margins for NAPCO Security Technologies in Q3</a></h4><ul><li>NAPCO Security (<a href='https://seekingalpha.com/symbol/NSSC' title='Napco Security Technologies, Inc.'>NSSC</a> <font color='green'>+2%</font>) reports recurring service revenue growth of 44% to $4.5M in <a href=\"https://seekingalpha.com/pr/17499958-napco-announces-third-quarter-fiscal-2019-results\" target=\"_blank\">Q3</a>.</li><li>Equipment revenues increased 8.2% Y/Y to $20.6M.</li><li>Gross margin rate improved 260 bps to 42.7%.</li><li>SG&amp;A expense rate leveraged 310 bps to 20.8%.</li><li>Adjusted operating margin rate grew 570 bps to 14.8%.</li><li>Adjusted EBITDA advanced 77% to $4.01M.</li><li>Mr. Soloway concluded, \"We are encouraged by our performance and look forward to a continuation of considerable sales and profit growth for the rest of our year. We will continue to make prudent investments in engineering and the marketing of product solutions which give us solid market positions in high-growth and recurring service revenue categories. All indicators and trends seem positive for the future and we look forward to concluding an exceptional Fiscal 2019.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459050-napco-security-beats-0_04-beats-revenue\" target=\"_blank\">NAPCO Security beats by $0.04, beats on revenue</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459123\" data-linked=\"Strong margins for NAPCO Security Technologies in Q3\" data-tweet=\"$NSSC - Strong margins for NAPCO Security Technologies in Q3 https://seekingalpha.com/news/3459123-strong-margins-for-napco-security-technologies-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3459123-strong-margins-for-napco-security-technologies-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3459121\" data-ts=\"1557150325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3459121-bofaml-steps-up-to-acacia-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML steps up to Acacia sidelines</a></h4><ul><li>Bank of America Merrill Lynch upgrades Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications, Inc.'>ACIA</a>) from Underperform to Neutral and raises the target from $40 to $64.</li><li>The firm sees potential from China's 5G rollout.</li><li>Acacia shares are <font color=\"red\">down 2.4%</font> on a rocky day for China-affiliated stocks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3459037-semis-slide-trumps-tariff-tweets\" target=\"_blank\">Semis could slide after Trump's tariff tweets</a> (May 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3459121\" data-linked=\"BofAML steps up to Acacia sidelines\" data-tweet=\"$ACIA - BofAML steps up to Acacia sidelines https://seekingalpha.com/news/3459121-bofaml-steps-up-to-acacia-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3459121-bofaml-steps-up-to-acacia-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}